<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00853658</url>
  </required_header>
  <id_info>
    <org_study_id>CSPP100F2301</org_study_id>
    <secondary_id>2008-004104-31</secondary_id>
    <nct_id>NCT00853658</nct_id>
  </id_info>
  <brief_title>Efficacy and Safety of Aliskiren and Aliskiren/Enalapril Combination on Morbidity-mortality in Patients With Chronic Heart Failure</brief_title>
  <acronym>ATMOSPHERE</acronym>
  <official_title>A Multicenter, Randomized, Double-blind, Parallel Group, Active-controlled Study to Evaluate the Efficacy and Safety of Both Aliskiren Monotherapy and Aliskiren/Enalapril Combination Therapy Compared to Enalapril Monotherapy, on Morbidity and Mortality in Patients With Chronic Heart Failure (NYHA Class II - IV). The Study is Also Known as Aliskiren Trial of Minimizing OutcomeS in Patients With HEart Failure (ATMOSPHERE).</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Novartis Pharmaceuticals</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Novartis</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study will evaluate the efficacy and safety of both aliskiren monotherapy and
      aliskiren/enalapril combination therapy as compared to enalapril monotherapy, on morbidity
      and mortality in patients with chronic heart failure (NYHA Class II - IV.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>March 2009</start_date>
  <completion_date type="Actual">October 2015</completion_date>
  <primary_completion_date type="Actual">October 2015</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of Participants That Had First Occurrence of the Composite Endpoint, Which is Defined as Either Cardiovascular (CV) Death or Heart Failure (HF) Hospitalization</measure>
    <time_frame>up to End of Study (78 months)</time_frame>
    <description>Number of participants that had first occurrence of the composite endpoint, which is defined as either CV death or HF hospitalization due to HF.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change From Baseline to Month 12 for the Kansas City Cardiomyopathy Questionnaire (KCCQ) Clinical Summary Score</measure>
    <time_frame>Baseline, Month 12</time_frame>
    <description>Change from baseline to Month 12 for the Kansas City Cardiomyopathy Questionnaire (KCCQ) clinical summary score. KCCQ is a 23-item, self-administered instrument that quantifies physical function, symptoms (frequency, severity and recent change), social function, self-efficacy and knowledge, and quality of life. KCCQ clinical summary score is a composite assessment of physical limitations and total symptom scores. Scores are transformed to a range of 0-100, in which higher scores reflect better health status.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>All Cause Death</measure>
    <time_frame>up to end of study (78 months)</time_frame>
    <description>Number of patients - All-cause death. All-cause death is common in Heart Failure HF patients this measures how many patients had this event.</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">7064</enrollment>
  <condition>Chronic Heart Failure</condition>
  <arm_group>
    <arm_group_label>Combination Aliskiren / Enalapril</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Aliskiren / Enalapril combination therapy-150 mg/10 mg titrated to 300 mg/ 10 mg film-coated tablets and administered orally.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Aliskiren</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Aliskiren monotherapy - 150 mg titrated to 300 mg film-coated tablets and administered orally.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Enalapril</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Enalapril monotherapy -10 mg film-coated tablet and administered orally.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Enalapril</intervention_name>
    <description>Enalapril 10 mg film-coated tablet and administered orally.</description>
    <arm_group_label>Combination Aliskiren / Enalapril</arm_group_label>
    <arm_group_label>Enalapril</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Aliskiren</intervention_name>
    <description>Aliskiren 150 mg titrated to 300 mg film-coated tablet and administered orally.</description>
    <arm_group_label>Combination Aliskiren / Enalapril</arm_group_label>
    <arm_group_label>Aliskiren</arm_group_label>
    <other_name>SPP100</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria

        Patients eligible for inclusion in this study had to fulfill all of the following criteria:

          1. Patients ≥ 18 years of age, male or female.

          2. Patients with a diagnosis of chronic heart failure (NYHA

             Class II - IV):

               1. LVEF ≤ 35% at Visit 1 (local measurement, within the past 6 months assessed by
                  echocardiography, multiple uptake gated acquisition scan (MUGA), computerized
                  tomography(CT) scan, magnetic resonance imaging (MRI) or ventricular angiography)

               2. Elevated BNP or NT-proBNP at Visit 1:

             BNP ≥ 150 pg/mL (or BNP ≥ 100 pg/mL and unplanned hospitalization for HF within the
             last 12 months prior to Visit 1) (according to local measurement). OR NT-proBNP ≥ 600
             pg/mL (or NT-proBNP ≥ 400 pg/mL and unplanned hospitalization for HF within the last
             12 months prior to Visit 1) (according to local measurement).

          3. Patients had to be treated with an ACEI at a stable dose enalapril 10 mg daily at
             least or any other ACEI, e.g. ramipril, quinapril, lisinopril, fosinopril,
             perindopril, trandolapril; based on equivalent doses, for at least 4 weeks prior to
             Visit 1

          4. Patients had to be treated with a beta-blocker, unless contraindicated or not
             tolerated, at a stable dose for at least 4 weeks prior to visit 1 (for patients not on
             target dose, according to local guidelines, or in absence of that medication, the
             reason should be documented).

          5. Written informed consent to participate in the study and ability to comply with all
             requirements.

        Exclusion Criteria

        Patients with any of the following were to be excluded from participation in the study:

          1. History of hypersensitivity to any of the study drugs including history or allergy to
             ACEIs as well as known or suspected contraindications to the study drugs or previous
             history of intolerance to high doses of ACEIs during up- titration process.

          2. Patients treated concomitantly with both an ARB and an aldosterone antagonist in
             addition to study drug at Visit 1.

          3. Current acute decompensated HF (defined as an acute exacerbation of a chronic heart
             failure status manifested by typical signs and symptoms of HF like dyspnea, fatigue
             etc., that may require IV therapy with diuretics, vasodilators and/or inotropic
             drugs).

          4. Symptomatic hypotension and/or less than 95 mmHg systolic blood pressure (SBP) at
             Visit 1 and/or less than 90 mmHg SBP at Visit 4.

          5. Acute coronary syndrome, stroke, transient ischemic attack, cardiac, carotid or major
             vascular surgery, percutaneous coronary intervention (PCI) or carotid angioplasty,
             within the past 3 months prior to Visit 1.

          6. Coronary or carotid artery disease likely to require surgical or percutaneous
             intervention within the 6 months after Visit 1.

          7. Right heart failure due to severe pulmonary disease.

          8. Patients with Diabetes Mellitus.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Novartis Pharmaceuticals</last_name>
    <role>Study Director</role>
    <affiliation>Novartis Pharmaceuticals</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Huntsville</city>
        <state>Alabama</state>
        <zip>35801</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Mobile</city>
        <state>Alabama</state>
        <zip>36608</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Mobile</city>
        <state>Alabama</state>
        <zip>36693</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Tucson</city>
        <state>Arizona</state>
        <zip>85723-0001</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Hot Springs</city>
        <state>Arkansas</state>
        <zip>71913</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Little Rock</city>
        <state>Arkansas</state>
        <zip>72204</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Little Rock</city>
        <state>Arkansas</state>
        <zip>72205</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Pine Bluff</city>
        <state>Arkansas</state>
        <zip>71603</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Searcy</city>
        <state>Arkansas</state>
        <zip>72143</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Beverly Hills</city>
        <state>California</state>
        <zip>90211</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>French Camp</city>
        <state>California</state>
        <zip>95231</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Inglewood</city>
        <state>California</state>
        <zip>90301</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90073</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Modesto</city>
        <state>California</state>
        <zip>95355</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Northridge</city>
        <state>California</state>
        <zip>91325</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Sacramento</city>
        <state>California</state>
        <zip>95825</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92123</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Santa Monica</city>
        <state>California</state>
        <zip>90404</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Westlake Village</city>
        <state>California</state>
        <zip>91361</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Denver</city>
        <state>Colorado</state>
        <zip>80218</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Littleton</city>
        <state>Colorado</state>
        <zip>80120</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Boynton Beach</city>
        <state>Florida</state>
        <zip>33437</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Daytona Beach</city>
        <state>Florida</state>
        <zip>32117</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Fort Lauderdale</city>
        <state>Florida</state>
        <zip>33316</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Hollywood</city>
        <state>Florida</state>
        <zip>33021</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Jacksonville Beach</city>
        <state>Florida</state>
        <zip>32050</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Miami Lakes</city>
        <state>Florida</state>
        <zip>33014</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Orlando</city>
        <state>Florida</state>
        <zip>32803</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Wellington</city>
        <state>Florida</state>
        <zip>33449</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Athens</city>
        <state>Georgia</state>
        <zip>30606</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Augusta</city>
        <state>Georgia</state>
        <zip>30904</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Gillespie</city>
        <state>Illinois</state>
        <zip>62033</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Topeka</city>
        <state>Kansas</state>
        <zip>66606</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Metairie</city>
        <state>Louisiana</state>
        <zip>70006</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>New Orleans</city>
        <state>Louisiana</state>
        <zip>70121</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Slidell</city>
        <state>Louisiana</state>
        <zip>70458</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Auburn</city>
        <state>Maine</state>
        <zip>04210</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Southfield</city>
        <state>Michigan</state>
        <zip>48075</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>St. Louis</city>
        <state>Missouri</state>
        <zip>63110</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Lincoln</city>
        <state>Nebraska</state>
        <zip>68506</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Omaha</city>
        <state>Nebraska</state>
        <zip>68198</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Elmer</city>
        <state>New Jersey</state>
        <zip>08318</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Laurelton</city>
        <state>New York</state>
        <zip>11422</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Stony Brook</city>
        <state>New York</state>
        <zip>11794</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Wiliamsville</city>
        <state>New York</state>
        <zip>14221</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Durham</city>
        <state>North Carolina</state>
        <zip>27710</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Marion</city>
        <state>Ohio</state>
        <zip>43302</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Charleston</city>
        <state>South Carolina</state>
        <zip>29403</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Varnville</city>
        <state>South Carolina</state>
        <zip>29944</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Germantown</city>
        <state>Tennessee</state>
        <zip>38138</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Memphis</city>
        <state>Tennessee</state>
        <zip>38120</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <zip>37205</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <zip>37212</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75226</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77021</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Everett</city>
        <state>Washington</state>
        <zip>98208</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Kirkland</city>
        <state>Washington</state>
        <zip>98034</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Bahia Blanca</city>
        <state>Buenos Aires</state>
        <zip>8000</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Caba</city>
        <state>Buenos Aires</state>
        <zip>C1180AAX</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Caba</city>
        <state>Buenos Aires</state>
        <zip>C1408INH</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Caba</city>
        <state>Buenos Aires</state>
        <zip>C1416DRJ</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Coronel Suarez</city>
        <state>Buenos Aires</state>
        <zip>B7540GHD</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>La Plata</city>
        <state>Buenos Aires</state>
        <zip>1900</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Quilmes</city>
        <state>Buenos Aires</state>
        <zip>B1878GEG</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Ramos Mejia</city>
        <state>Buenos Aires</state>
        <zip>B1704ETD</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>San Isidro</city>
        <state>Buenos Aires</state>
        <zip>B1642DCD</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>San Nicolas</city>
        <state>Buenos Aires</state>
        <zip>B2900DMH</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Córdoba</city>
        <state>Cordoba</state>
        <zip>X5152HQC</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Va Allende</city>
        <state>Cordoba</state>
        <zip>5105</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Villa Maria</city>
        <state>Cordoba</state>
        <zip>X5220XAO</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Posadas</city>
        <state>Misiones</state>
        <zip>N3300AHX</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Tucuman</city>
        <state>San Miguel de Tucuman</state>
        <zip>T4000ICL</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Rosario</city>
        <state>Santa Fe</state>
        <zip>S2000CXH</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Rosario</city>
        <state>Santa Fe</state>
        <zip>S2000DFD</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Rosario</city>
        <state>Santa Fe</state>
        <zip>S2000DSV</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Rosario</city>
        <state>Santa Fe</state>
        <zip>S2001ODA</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>San Miguel de Tucuman</city>
        <state>Tucuman</state>
        <zip>T4000IFL</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Buenos Aires</city>
        <zip>C1094AAD</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Buenos Aires</city>
        <zip>C1428DCO</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Cordoba</city>
        <zip>X5000AAI</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Cordoba</city>
        <zip>X5000AVI</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Cordoba</city>
        <zip>X5000EPU</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Cordoba</city>
        <zip>X5000EVQ</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Cordoba</city>
        <zip>X5000FGG</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Cordoba</city>
        <zip>X5002AOQ</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Cordoba</city>
        <zip>X5003DCE</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Cordoba</city>
        <zip>X5004BAL</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Cordoba</city>
        <zip>X5006IKK</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Cordoba</city>
        <zip>X5009BSN</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Cordoba</city>
        <zip>X5022CPU</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Cordoba</city>
        <zip>X5220XAO</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Corrientes</city>
        <zip>W3400CBI</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Corrientes</city>
        <zip>W3400</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Salta</city>
        <zip>4400</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Canberra</city>
        <state>Australian Capital Territory</state>
        <zip>2605</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Darlinghurst</city>
        <state>New South Wales</state>
        <zip>2010</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Kingswood</city>
        <state>New South Wales</state>
        <zip>2747</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Wollongong</city>
        <state>New South Wales</state>
        <zip>2500</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Auchenflower</city>
        <state>Queensland</state>
        <zip>4066</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Woolloongabba</city>
        <state>Queensland</state>
        <zip>4101</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Wooloongabba</city>
        <state>Queensland</state>
        <zip>4102</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Bedford Park</city>
        <state>South Australia</state>
        <zip>5042</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Launceston</city>
        <state>Tasmania</state>
        <zip>7250</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Geelong</city>
        <state>Victoria</state>
        <zip>3220</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Prahran</city>
        <state>Victoria</state>
        <zip>3181</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Innsbruck</city>
        <state>Tyrol</state>
        <zip>6020</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Graz</city>
        <zip>A-8036</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Linz</city>
        <zip>4010</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Linz</city>
        <zip>A-4010</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Salzburg</city>
        <zip>A-5020</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Vienna</city>
        <zip>1030</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Vienna</city>
        <zip>1140</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Wien</city>
        <zip>A-1090</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Wien</city>
        <zip>A-1160</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Anderlecht</city>
        <zip>1070</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Brugge</city>
        <zip>8000</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Brussels</city>
        <zip>1180</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Bruxelles</city>
        <zip>1200</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>De Pinte</city>
        <zip>9840</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Eupen</city>
        <zip>4700</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Genk</city>
        <zip>3600</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Huy</city>
        <zip>4500</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Ieper</city>
        <zip>8900</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Leuven</city>
        <zip>3000</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Liege</city>
        <zip>4000</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Turnhout</city>
        <zip>2300</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Fortaleza</city>
        <state>CE</state>
        <zip>60864-190</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Brasilia</city>
        <state>DF</state>
        <zip>70658-700</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Goiania</city>
        <state>GO</state>
        <zip>74605-050</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Belo Horizonte</city>
        <state>MG</state>
        <zip>30110-934</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Belo Horizonte</city>
        <state>MG</state>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Recife</city>
        <state>PE</state>
        <zip>50100-060</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Campina Grande do Sul</city>
        <state>PR</state>
        <zip>83430-000</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Curitiba</city>
        <state>PR</state>
        <zip>80010-030</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Londrina</city>
        <state>PR</state>
        <zip>86051-990</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Rio de Janeiro</city>
        <state>RJ</state>
        <zip>22240-006</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Caxias do Sul</city>
        <state>RS</state>
        <zip>95070-560</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Porto Alegre</city>
        <state>RS</state>
        <zip>90020-090</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Porto Alegre</city>
        <state>RS</state>
        <zip>90035-903</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Porto Alegre</city>
        <state>RS</state>
        <zip>90560-030</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Porto Alegre</city>
        <state>RS</state>
        <zip>90610-000</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Campinas</city>
        <state>SP</state>
        <zip>13020-431</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Campinas</city>
        <state>SP</state>
        <zip>13060-904</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Campinas</city>
        <state>SP</state>
        <zip>13083-190</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Marilia</city>
        <state>SP</state>
        <zip>17519-030</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>São Paulo</city>
        <state>SP</state>
        <zip>05403-900</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Tatuí</city>
        <state>SP</state>
        <zip>18270-170</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Calgary</city>
        <state>Alberta</state>
        <zip>T2N 4Z6</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>St. John</city>
        <state>New Brunswick</state>
        <zip>E2L 4L2</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Brampton</city>
        <state>Ontario</state>
        <zip>L6Z 4N5</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Cambridge</city>
        <state>Ontario</state>
        <zip>N1R 6V6</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Ottawa</city>
        <state>Ontario</state>
        <zip>K1Y 4W7</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Joliette</city>
        <state>Quebec</state>
        <zip>J6E 6J2</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Montreal</city>
        <state>Quebec</state>
        <zip>H1T 1C8</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Montreal</city>
        <state>Quebec</state>
        <zip>H1T 3Y7</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Québec</city>
        <state>Quebec</state>
        <zip>G1J 1Z6</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Sainte-Foy</city>
        <state>Quebec</state>
        <zip>G1V 4G5</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>100083</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>100088</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>100730</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Fuzhou</city>
        <state>Fujian</state>
        <zip>350001</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Guangzhou</city>
        <state>Guangdong</state>
        <zip>510080</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Guangzhou</city>
        <state>Guangdong</state>
        <zip>510515</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Shijiazhuang</city>
        <state>Hebei</state>
        <zip>050000</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Wuhan</city>
        <state>Hubei</state>
        <zip>430022</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Nanjing</city>
        <state>Jiangsu</state>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Suzhou</city>
        <state>Jiangsu</state>
        <zip>215004</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Changchun</city>
        <state>Jilin</state>
        <zip>130021</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Shenyang</city>
        <state>Liaoning</state>
        <zip>110003</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Shenyang</city>
        <state>Liaoning</state>
        <zip>110016</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <zip>200011</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Tianjin</city>
        <state>Tianjin</state>
        <zip>300121</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Hangzhou</city>
        <state>Zhejiang</state>
        <zip>310006</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Hangzhou</city>
        <state>Zhejiang</state>
        <zip>310009</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Hangzhou</city>
        <state>Zhejiang</state>
        <zip>310013</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Hangzhou</city>
        <state>Zhejiang</state>
        <zip>310016</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Baotou</city>
        <zip>014040</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Beijing</city>
        <zip>100020</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Beijing</city>
        <zip>100028</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Beijing</city>
        <zip>100029</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Beijing</city>
        <zip>100034</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Beijing</city>
        <zip>100044</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Beijing</city>
        <zip>100050</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Guang zhou</city>
        <zip>510080</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Jinan</city>
        <zip>250012</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Shanghai</city>
        <zip>200025</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Shanghai</city>
        <zip>200032</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Shanghai</city>
        <zip>200233</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Tianjin</city>
        <zip>300142</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Xian</city>
        <zip>710004</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Medellín</city>
        <state>Antioquia</state>
        <country>Colombia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Baranquilla</city>
        <state>Atlantico</state>
        <country>Colombia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Barranquilla</city>
        <state>Atlantico</state>
        <country>Colombia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Cartagena</city>
        <state>Bolivar</state>
        <country>Colombia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Bogota</city>
        <state>Cundinamarca</state>
        <zip>111411</zip>
        <country>Colombia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Bogotá</city>
        <state>Cundinamarca</state>
        <zip>110111</zip>
        <country>Colombia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Barranquilla</city>
        <country>Colombia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Bogotá</city>
        <zip>00000</zip>
        <country>Colombia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Bogotá</city>
        <country>Colombia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Florida Blanca</city>
        <country>Colombia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Medellín</city>
        <country>Colombia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Goicoechea</city>
        <state>San Jose, Costa Rica</state>
        <zip>3184-1000</zip>
        <country>Costa Rica</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Alajuela</city>
        <country>Costa Rica</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>San Jose</city>
        <zip>1307-1000</zip>
        <country>Costa Rica</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>San Jose</city>
        <zip>272-1225</zip>
        <country>Costa Rica</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Benesov</city>
        <zip>25601</zip>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Brno</city>
        <zip>60200</zip>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Cesky Krumlov</city>
        <zip>381 01</zip>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Jindrichuv Hradec</city>
        <zip>377 01</zip>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Kolín</city>
        <zip>280 02</zip>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Kromeriz</city>
        <zip>767 01</zip>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Louny</city>
        <zip>440 01</zip>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Louny</city>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Marianske lazne</city>
        <zip>353 01</zip>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Ostrava</city>
        <zip>70200</zip>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Plzen</city>
        <zip>323 00</zip>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Praha 11</city>
        <zip>148 00</zip>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Praha 2</city>
        <zip>128 08</zip>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Praha 9</city>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Pribram VIII</city>
        <zip>261 01</zip>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Teplice</city>
        <zip>415 01</zip>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Vyskov</city>
        <zip>68001</zip>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Aalborg</city>
        <zip>DK-9000</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Copenhagen NV</city>
        <zip>DK-2400</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Copenhagen S</city>
        <zip>DK-2300</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Copenhagen</city>
        <zip>2100</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Esbjerg</city>
        <zip>DK-6700</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Fredericia</city>
        <zip>7000</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Frederiksberg</city>
        <zip>DK-2000</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Glostrup</city>
        <zip>DK-2600</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Hellerup</city>
        <zip>DK-2900</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Helsingoer</city>
        <zip>DK-3000</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Hillerød</city>
        <zip>DK-3400</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Hjørring</city>
        <zip>DK-9800</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Holbæk</city>
        <zip>DK-4300</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Hvidovre</city>
        <zip>DK-2650</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Køge</city>
        <zip>DK-4600</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Næstved</city>
        <zip>DK-4700</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Odense C</city>
        <zip>DK-5000</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Randers NØ</city>
        <zip>DK-8930</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Silkeborg</city>
        <zip>8600</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Svendborg</city>
        <zip>DK-5700</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Viborg</city>
        <zip>DK-8800</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Århus N</city>
        <zip>DK-8200</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Santo Domingo</city>
        <state>Republica Dominicana</state>
        <country>Dominican Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>San Cristobal</city>
        <country>Dominican Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Parnu</city>
        <zip>80010</zip>
        <country>Estonia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Tallinn</city>
        <zip>10138</zip>
        <country>Estonia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Tallinn</city>
        <zip>13419</zip>
        <country>Estonia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Tartu</city>
        <zip>51014</zip>
        <country>Estonia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Hyvinkää</city>
        <zip>FIN-05850</zip>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Jyvaskyla</city>
        <zip>FIN-40620</zip>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Seinajoki</city>
        <zip>60200</zip>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Tammisaari</city>
        <zip>10600</zip>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Turku</city>
        <zip>FIN-20520</zip>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Albi</city>
        <zip>81013</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Angers</city>
        <zip>49000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Becon Les Granits</city>
        <zip>49370</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Clichy</city>
        <zip>92110</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Dijon</city>
        <zip>21079</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Grenoble</city>
        <zip>38043</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Marseille Cedex 05</city>
        <zip>13385</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Marseille</city>
        <zip>13915</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Paris</city>
        <zip>75013</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Paris</city>
        <zip>75571</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Pessac Cedex</city>
        <zip>33604</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Saint-Etienne</city>
        <zip>42055</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Vandoeuvre Les Nancy</city>
        <zip>54511</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Winsen (Luhe)</city>
        <state>Lower Saxony</state>
        <zip>21423</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Augsburg</city>
        <zip>86150</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Bad Nauheim</city>
        <zip>61231</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Bad Neustadt an der Saale</city>
        <zip>97616</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Bensheim</city>
        <zip>64625</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Berlin</city>
        <zip>10367</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Berlin</city>
        <zip>10789</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Berlin</city>
        <zip>12163</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Berlin</city>
        <zip>12351</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Berlin</city>
        <zip>12552</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Berlin</city>
        <zip>13353</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Berlin</city>
        <zip>13405</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Bochum</city>
        <zip>44791</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Bonn</city>
        <zip>53115</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Bonn</city>
        <zip>53127</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Bonn</city>
        <zip>53225</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Brake</city>
        <zip>26919</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Celle</city>
        <zip>29223</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Chemnitz</city>
        <zip>09113</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Chemnitz</city>
        <zip>09116</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Chemnitz</city>
        <zip>09126</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Coburg</city>
        <zip>96450</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Darmstadt</city>
        <zip>64283</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Dessau-Roßlau</city>
        <zip>06846</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Dinkelsbühl</city>
        <zip>91550</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Dorsten</city>
        <zip>46282</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Dortmund</city>
        <zip>44137</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Dresden</city>
        <zip>01067</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Dresden</city>
        <zip>01097</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Dresden</city>
        <zip>01219</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Dresden</city>
        <zip>01277</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Dresden</city>
        <zip>01309</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Duisburg</city>
        <zip>47051</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Duisburg</city>
        <zip>47139</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Düsseldorf</city>
        <zip>40593</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Ebersbach</city>
        <zip>02730</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Erfurt</city>
        <zip>99084</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Erkner</city>
        <zip>15537</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Essen</city>
        <zip>45136</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Essen</city>
        <zip>45355</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Frankfurt</city>
        <zip>60594</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Goettingen</city>
        <zip>37075</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Gotha</city>
        <zip>99867</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Göttingen</city>
        <zip>37073</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Gütersloh</city>
        <zip>33332</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Halle (Saale)</city>
        <zip>06120</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Halle/Saale</city>
        <zip>06120</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Hamburg</city>
        <zip>20099</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Hannover</city>
        <zip>30167</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Hassloch</city>
        <zip>67454</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Heidelberg</city>
        <zip>69115</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Heidelberg</city>
        <zip>69120</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Heilbronn</city>
        <zip>74078</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Helmbrechts</city>
        <zip>95223</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Heppenheim</city>
        <zip>64646</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Kassel</city>
        <zip>34127</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Kleve</city>
        <zip>47533</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Koblenz</city>
        <zip>56068</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Krefeld</city>
        <zip>47798</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Köln</city>
        <zip>51605</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Königsbrück</city>
        <zip>01436</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Köthen</city>
        <zip>06366</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Lambrecht</city>
        <zip>67466</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Landshut</city>
        <zip>84034</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Leipzig</city>
        <zip>04177</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Lichtentanne</city>
        <zip>08115</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Lienen</city>
        <zip>49536</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Ludwigsburg</city>
        <zip>71634</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Lörrach</city>
        <zip>79539</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Lüneburg</city>
        <zip>21339</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Magdeburg</city>
        <zip>39110</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Mainz</city>
        <zip>55116</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Markkleeberg</city>
        <zip>04416</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Mayen</city>
        <zip>56727</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Melsungen</city>
        <zip>34212</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Muehldorf am Inn</city>
        <zip>84453</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Muehlheim an der Ruhr</city>
        <zip>45468</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Muenchen</city>
        <zip>80636</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Mülheim</city>
        <zip>45468</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Northeim</city>
        <zip>37154</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Nürnberg</city>
        <zip>90471</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Oelde</city>
        <zip>59302</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Oelde</city>
        <zip>59303</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Pirna</city>
        <zip>01796</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Potsdam</city>
        <zip>14471</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Reinfeld</city>
        <zip>23858</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Salzwedel</city>
        <zip>29410</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Schwalmstadt</city>
        <zip>34613</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Schwäbisch Hall</city>
        <zip>74523</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Siegen</city>
        <zip>57072</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Solingen</city>
        <zip>42651</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Stade</city>
        <zip>21682</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Stuttgart</city>
        <zip>70372</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Stuttgart</city>
        <zip>70378</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Wedel</city>
        <zip>22880</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Witten</city>
        <zip>58455</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Wuerzburg</city>
        <zip>97078</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Zwickau</city>
        <zip>08056</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Athens</city>
        <state>GR</state>
        <zip>115 27</zip>
        <country>Greece</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Thessaloniki</city>
        <state>GR</state>
        <zip>546 36</zip>
        <country>Greece</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Thessaloniki</city>
        <state>GR</state>
        <zip>570 10</zip>
        <country>Greece</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Athens</city>
        <zip>115 28</zip>
        <country>Greece</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Athens</city>
        <zip>124 62</zip>
        <country>Greece</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Athens</city>
        <zip>GR 11527</zip>
        <country>Greece</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Chios</city>
        <zip>82100</zip>
        <country>Greece</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Edessa</city>
        <zip>58200</zip>
        <country>Greece</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Guntur</city>
        <state>Andhra Pradesh</state>
        <zip>522001</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Hyderabad</city>
        <state>Andhra Pradesh</state>
        <zip>500012</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Secunderabad</city>
        <state>Andhra Pradesh</state>
        <zip>500003</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Vijayawada</city>
        <state>Andhra Pradesh</state>
        <zip>520 008</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>New Delhi</city>
        <state>Delhi</state>
        <zip>110060</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Ahmedabad</city>
        <state>Gujarat</state>
        <zip>380 051</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Bangalore</city>
        <state>Karnataka</state>
        <zip>560 052</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Bangalore</city>
        <state>Karnataka</state>
        <zip>560099</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Manipal</city>
        <state>Karnataka</state>
        <zip>576104</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Trivandrum</city>
        <state>Kerela</state>
        <zip>695002</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Mumbai</city>
        <state>Maharashtra</state>
        <zip>400 022</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Nagpur</city>
        <state>Maharashtra</state>
        <zip>400 008</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Nagpur</city>
        <state>Maharashtra</state>
        <zip>400 012</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Nagpur</city>
        <state>Maharashtra</state>
        <zip>400012</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Nagpur</city>
        <state>Maharashtra</state>
        <zip>440 010</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Nagpur</city>
        <state>Maharashtra</state>
        <zip>440010</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Nagpur</city>
        <state>Maharashtra</state>
        <zip>440012</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Pune</city>
        <state>Maharashtra</state>
        <zip>411 011</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Pune</city>
        <state>Maharashtra</state>
        <zip>411 019</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Pune</city>
        <state>Maharashtra</state>
        <zip>411 044</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Pune</city>
        <state>Maharashtra</state>
        <zip>411004</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Pune</city>
        <state>Maharashtra</state>
        <zip>411011</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Delhi</city>
        <state>New Delhi</state>
        <zip>110065</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Jaipur</city>
        <state>Rajasthan</state>
        <zip>302001</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Jaipur</city>
        <state>Rajasthan</state>
        <zip>302024</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Chennai</city>
        <state>Tamil Nadu</state>
        <zip>600100</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Coimbatore</city>
        <state>Tamil Nadu</state>
        <zip>641014</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Madurai</city>
        <state>Tamil Nadu</state>
        <zip>625107</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Hyderabad</city>
        <state>Telangana</state>
        <zip>500082</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Lucknow</city>
        <state>Uttar Pradesh</state>
        <zip>226005</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Lucknow</city>
        <state>Uttar Pradesh</state>
        <zip>226014</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Bangalore</city>
        <zip>560 034</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Hyderabad</city>
        <zip>500 063</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Hyderabad</city>
        <zip>500044</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Lucknow</city>
        <zip>226003</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Mumbai</city>
        <zip>400 050</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>New Delhi</city>
        <zip>110044</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Noida</city>
        <zip>201301</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Co Dublin</city>
        <country>Ireland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Dublin 7</city>
        <country>Ireland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Dublin</city>
        <zip>9</zip>
        <country>Ireland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Dublin</city>
        <country>Ireland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Galway</city>
        <country>Ireland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Montescano</city>
        <state>(pv)</state>
        <zip>27040</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Pavia</city>
        <state>(pv)</state>
        <zip>27100</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Ancona</city>
        <state>AN</state>
        <zip>60126</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Arezzo</city>
        <state>AR</state>
        <zip>52100</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Cortona</city>
        <state>AR</state>
        <zip>52044</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Bergamo</city>
        <state>BG</state>
        <zip>24128</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Bologna</city>
        <state>BO</state>
        <zip>40138</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Brescia</city>
        <state>BS</state>
        <zip>25123</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Lumezzane</city>
        <state>BS</state>
        <zip>25065</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Chieti</city>
        <state>CH</state>
        <zip>66100</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Cosenza</city>
        <state>CS</state>
        <zip>87100</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Forlì</city>
        <state>FC</state>
        <zip>47100</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Cona</city>
        <state>FE</state>
        <zip>44100</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Foggia</city>
        <state>FG</state>
        <zip>71100</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Firenze</city>
        <state>FI</state>
        <zip>50143</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Pozzilli</city>
        <state>IS</state>
        <zip>86077</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Casarano</city>
        <state>LE</state>
        <zip>73042</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Cecina</city>
        <state>LI</state>
        <zip>57023</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Castelnuovo di Garfagnana</city>
        <state>LU</state>
        <zip>55032</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Milano</city>
        <state>MI</state>
        <zip>20132</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Milano</city>
        <state>MI</state>
        <zip>20138</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Passirana di Rho</city>
        <state>MI</state>
        <zip>20017</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Pieve di Coriano</city>
        <state>MN</state>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Massa</city>
        <state>MS</state>
        <zip>54100</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Palermo</city>
        <state>PA</state>
        <zip>90127</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Perugia</city>
        <state>PG</state>
        <zip>06129</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Parma</city>
        <state>PR</state>
        <zip>43100</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Pavia</city>
        <state>PV</state>
        <zip>27100</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Cotignola</city>
        <state>RA</state>
        <zip>48010</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Roma</city>
        <state>RM</state>
        <zip>00169</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Roma</city>
        <state>RM</state>
        <zip>00184</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Roma</city>
        <state>RM</state>
        <zip>00189</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Rimini</city>
        <state>RN</state>
        <zip>47900</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Cava De' Tirreni</city>
        <state>SA</state>
        <zip>84013</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Poggibonsi</city>
        <state>SI</state>
        <zip>53036</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Sondalo</city>
        <state>SO</state>
        <zip>23035</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Sarzana</city>
        <state>SP</state>
        <zip>19038</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Sassari</city>
        <state>SS</state>
        <zip>07100</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Orbassano</city>
        <state>TO</state>
        <zip>10043</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Torino</city>
        <state>TO</state>
        <zip>10126</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Terni</city>
        <state>TR</state>
        <zip>05100</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Trieste</city>
        <state>TS</state>
        <zip>34142</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Trieste</city>
        <state>TS</state>
        <zip>34149</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Vittorio Veneto</city>
        <state>TV</state>
        <zip>31029</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>San Daniele Del Friuli</city>
        <state>UD</state>
        <zip>33038</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Udine</city>
        <state>UD</state>
        <zip>33100</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Tradate</city>
        <state>VA</state>
        <zip>21049</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>San Bonifacio</city>
        <state>VR</state>
        <zip>37047</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Nagoya-city</city>
        <state>Aichi</state>
        <zip>466-8560</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Seto-city</city>
        <state>Aichi</state>
        <zip>489-8642</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Chiba-city</city>
        <state>Chiba</state>
        <zip>260-8677</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Inba-gun</city>
        <state>Chiba</state>
        <zip>270-1694</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Chikushino-city</city>
        <state>Fukuoka</state>
        <zip>818-8502</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Fukuoka-city</city>
        <state>Fukuoka</state>
        <zip>814-0180</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Iizuka-city</city>
        <state>Fukuoka</state>
        <zip>820-8505</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Kurume-city</city>
        <state>Fukuoka</state>
        <zip>830-8577</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Ogaki-city</city>
        <state>Gifu</state>
        <zip>503-8502</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Hiroshima-city</city>
        <state>Hiroshima</state>
        <zip>734-8551</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Kure</city>
        <state>Hiroshima</state>
        <zip>737-0023</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Sapporo-city</city>
        <state>Hokkaido</state>
        <zip>060-8648</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Sapporo-city</city>
        <state>Hokkaido</state>
        <zip>063-0005</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Amagasaki-city</city>
        <state>Hyogo</state>
        <zip>660-8550</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Higashiibaraki-gun</city>
        <state>Ibaraki</state>
        <zip>311-3193</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Hitachinaka</city>
        <state>Ibaraki</state>
        <zip>312-0057</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Tsukuba-city</city>
        <state>Ibaraki</state>
        <zip>305-8576</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Kanazawa</city>
        <state>Ishikawa</state>
        <zip>920-8650</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Kawasaki-city</city>
        <state>Kanagawa</state>
        <zip>210-0852</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Sagamihara-city</city>
        <state>Kanagawa</state>
        <zip>252-0375</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Yokohama-city</city>
        <state>Kanagawa</state>
        <zip>232-0024</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Yokosuka</city>
        <state>Kanagawa</state>
        <zip>238-8567</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Kumamoto City</city>
        <state>Kumamoto</state>
        <zip>860-8556</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Sendai-city</city>
        <state>Miyagi</state>
        <zip>980-8574</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Kashihara-city</city>
        <state>Nara</state>
        <zip>634-8522</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Okayama-city</city>
        <state>Okayama</state>
        <zip>702-8055</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Izumisano-city</city>
        <state>Osaka</state>
        <zip>598-8577</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Kita-ku</city>
        <state>Osaka</state>
        <zip>530-0001</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Osaka-city</city>
        <state>Osaka</state>
        <zip>545-8586</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Ureshino</city>
        <state>Saga</state>
        <zip>843-0393</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Hamada</city>
        <state>Shimane</state>
        <zip>697-8511</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Komatsushima-city</city>
        <state>Tokushima</state>
        <zip>773-8502</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Tokushima-city</city>
        <state>Tokushima</state>
        <zip>770-8503</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Adachi-ku</city>
        <state>Tokyo</state>
        <zip>120-0006</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Bunkyo-ku</city>
        <state>Tokyo</state>
        <zip>113-8431</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Bunkyo-ku</city>
        <state>Tokyo</state>
        <zip>113-8519</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Bunkyo-ku</city>
        <state>Tokyo</state>
        <zip>113-8603</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Bunkyo-ku</city>
        <state>Tokyo</state>
        <zip>113-8655</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Shinjuku-ku</city>
        <state>Tokyo</state>
        <zip>162-8666</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Hofu</city>
        <state>Yamaguchi</state>
        <zip>747-8511</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Shunan-city</city>
        <state>Yamaguchi</state>
        <zip>745-8522</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Ube</city>
        <state>Yamaguchi</state>
        <zip>755-8505</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Fukushima</city>
        <zip>960-8251</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Nagasaki</city>
        <zip>850-8555</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Saga</city>
        <zip>849-8501</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Toyama</city>
        <zip>930-0194</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Seongnam</city>
        <state>Gyeonggi</state>
        <zip>13620</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Seoul</city>
        <state>Korea</state>
        <zip>03080</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Seoul</city>
        <state>Korea</state>
        <zip>03722</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Seoul</city>
        <state>Korea</state>
        <zip>05505</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Seoul</city>
        <state>Korea</state>
        <zip>06351</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Seoul</city>
        <state>Korea</state>
        <zip>152-703</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Busan</city>
        <zip>602-715</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Daejeon</city>
        <zip>302-241</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Gwangju</city>
        <zip>501-757</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Incheon</city>
        <zip>405-760</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Seoul</city>
        <zip>143-729</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Taegu</city>
        <zip>700 - 721</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Daugavpils</city>
        <zip>LV-5401</zip>
        <country>Latvia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Riga</city>
        <zip>1012</zip>
        <country>Latvia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Riga</city>
        <zip>LV-1012</zip>
        <country>Latvia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Riga</city>
        <zip>LV-1038</zip>
        <country>Latvia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Kaunas</city>
        <state>LTU</state>
        <zip>50009</zip>
        <country>Lithuania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Kaunas</city>
        <zip>LT-47144</zip>
        <country>Lithuania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Klaipeda</city>
        <zip>LT-92288</zip>
        <country>Lithuania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Vilnius</city>
        <zip>08661</zip>
        <country>Lithuania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Guadalajara</city>
        <state>Jalisco</state>
        <zip>44600</zip>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Zapopan</city>
        <state>Jalisco</state>
        <zip>45200</zip>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Monterrey</city>
        <state>Nuevo León</state>
        <zip>64060</zip>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Monterrey</city>
        <state>Nuevo León</state>
        <zip>64710</zip>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Culiacan</city>
        <state>Sinaloa</state>
        <zip>CP:83230</zip>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Aguascalientes</city>
        <zip>20230</zip>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Querétaro</city>
        <zip>76000</zip>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>San Luis Potosi</city>
        <zip>78200</zip>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Alkmaar</city>
        <zip>1815 JD</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Amsterdam</city>
        <zip>1023 NL</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Amsterdam</city>
        <zip>1061 AE</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Amsterdam</city>
        <zip>1091 HA</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Amsterdam</city>
        <zip>1105 AZ</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Apeldoorn</city>
        <zip>7334 DZ</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Deventer</city>
        <zip>7416 SE</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Dirksland</city>
        <zip>3247 BW</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Enschede</city>
        <zip>7513 ER</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Groningen</city>
        <zip>9713 GZ</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Haarlem</city>
        <zip>2035 RC</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Heerlen</city>
        <zip>6419 PC</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Leeuwarden</city>
        <zip>8934 AD</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Leiderdorp</city>
        <zip>NL-2353 GA</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Meppel</city>
        <zip>7943 KA</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Rotterdam</city>
        <zip>3045 PM</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Rotterdam</city>
        <zip>3083 AN</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Venlo</city>
        <zip>5912 BL</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Wildervank</city>
        <zip>9648 BE</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Zutphen</city>
        <zip>7207 AE</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Zwolle</city>
        <zip>8011 JW</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Oslo</city>
        <zip>0514</zip>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Trondheim</city>
        <zip>7006</zip>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Tønsberg</city>
        <zip>3116</zip>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Trujillo</city>
        <state>La Libertad</state>
        <country>Peru</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Chiclayo</city>
        <state>Lambayeque</state>
        <country>Peru</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Bellavista</city>
        <state>Lima</state>
        <zip>Callao 02</zip>
        <country>Peru</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Cercado de Lima</city>
        <state>Lima</state>
        <zip>01</zip>
        <country>Peru</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Jesus Maria</city>
        <state>Lima</state>
        <zip>11</zip>
        <country>Peru</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Miraflores</city>
        <state>Lima</state>
        <zip>18</zip>
        <country>Peru</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>San Borja</city>
        <state>Lima</state>
        <zip>41</zip>
        <country>Peru</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>San Isidro</city>
        <state>Lima</state>
        <zip>27</zip>
        <country>Peru</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>San Juan de Miraflores</city>
        <state>Lima</state>
        <zip>29</zip>
        <country>Peru</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Lima</city>
        <zip>Lima 39</zip>
        <country>Peru</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Bytom</city>
        <zip>41-902</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Chorzow</city>
        <zip>41-506</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Gdansk</city>
        <zip>80-180</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Gdynia</city>
        <zip>81-423</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Gdynia</city>
        <zip>81-519</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Gliwice</city>
        <zip>44-100</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Grodzisk Mazowiecki</city>
        <zip>05-825</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Katowice</city>
        <zip>40-040</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Katowice</city>
        <zip>40-084</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Klodzko</city>
        <zip>57-300</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Krakow</city>
        <zip>30-053</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Kraków</city>
        <zip>31-501</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Lomza</city>
        <zip>18-104</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Olawa</city>
        <zip>55-200</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Opole</city>
        <zip>45-706</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Ostrow Wielkopolski</city>
        <zip>63-400</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Ostrowiec Swietokrzyski</city>
        <zip>27-400</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Piotrkow Trybunalski</city>
        <zip>97-300</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Plock</city>
        <zip>09-402</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Poznan</city>
        <zip>61-485</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Sandomierz</city>
        <zip>27-600</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Tarnow</city>
        <zip>33-100</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Torun</city>
        <zip>87-100</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Warszawa</city>
        <zip>03-242</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Warszawa</city>
        <zip>04-628</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Wroclaw</city>
        <zip>50-349</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Wroclaw</city>
        <zip>50-420</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Wroclaw</city>
        <zip>50-981</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Wroclaw</city>
        <zip>52-612</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Zabrze</city>
        <zip>41-800</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Amadora</city>
        <zip>2720-276</zip>
        <country>Portugal</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Aveiro</city>
        <zip>3814-501</zip>
        <country>Portugal</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Carnaxide</city>
        <zip>2799-523</zip>
        <country>Portugal</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Coimbra</city>
        <zip>3000-075</zip>
        <country>Portugal</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Faro</city>
        <zip>8000-386</zip>
        <country>Portugal</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Lisboa</city>
        <zip>1495-005</zip>
        <country>Portugal</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Lisboa</city>
        <zip>1600-190</zip>
        <country>Portugal</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Lisboa</city>
        <zip>1769-001</zip>
        <country>Portugal</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Penafiel</city>
        <zip>4564-007</zip>
        <country>Portugal</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Porto</city>
        <zip>4200-319</zip>
        <country>Portugal</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Humacao</city>
        <zip>00791</zip>
        <country>Puerto Rico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Ponce</city>
        <zip>00717</zip>
        <country>Puerto Rico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>San Juan</city>
        <zip>00936-6528</zip>
        <country>Puerto Rico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Bucharest</city>
        <state>District 1</state>
        <zip>012051</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Bucharest</city>
        <state>District 1</state>
        <zip>012064</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Bucharest</city>
        <state>District 2</state>
        <zip>021705</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Iasi</city>
        <state>Jud Iasi</state>
        <zip>700005</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Targu Mures</city>
        <state>jud Mures</state>
        <zip>540043</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Iasi</city>
        <state>Jud. Iasi</state>
        <zip>700506</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Targu Mures</city>
        <state>Mures</state>
        <zip>540136</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Baia Mare</city>
        <zip>430123</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Brasov</city>
        <zip>500281</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Brasov</city>
        <zip>500427</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Cluj Napoca</city>
        <zip>400006</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Cluj-Napoca</city>
        <zip>400347</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Iasi</city>
        <zip>700547</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Oradea</city>
        <zip>410169</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Pitesti</city>
        <zip>110114</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Targu Mures</city>
        <zip>540096</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Timisoara</city>
        <zip>300310</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Timisoara</city>
        <zip>300736</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Barnaul</city>
        <zip>656055</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Chelyabinsk</city>
        <zip>454000</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Chelyabinsk</city>
        <zip>454021</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Chelyabinsk</city>
        <zip>454047</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Chelyabinsk</city>
        <zip>454048</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Ekaterinburg</city>
        <zip>620028</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Ekaterinburg</city>
        <zip>620137</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Izhevsk</city>
        <zip>426009</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Kirov</city>
        <zip>610014</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Krasnodar</city>
        <zip>350063</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Kursk</city>
        <zip>305035</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Lubertsi</city>
        <zip>140006</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Moscow</city>
        <zip>105229</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Moscow</city>
        <zip>111020</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Moscow</city>
        <zip>111539</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Moscow</city>
        <zip>115432</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Moscow</city>
        <zip>117292</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Moscow</city>
        <zip>119992</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Moscow</city>
        <zip>121359</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Moscow</city>
        <zip>127473</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Moscow</city>
        <zip>129301</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Moscow</city>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Nizhny Novgorod</city>
        <zip>603018</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Novosibirsk</city>
        <zip>630047</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Novosibirsk</city>
        <zip>630075</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Novosibirsk</city>
        <zip>630089</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Omsk</city>
        <zip>644018</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Perm</city>
        <zip>614097</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Pushkin,St-Petersburg</city>
        <zip>196601</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Ryazan</city>
        <zip>390026</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>S.-Petersburg</city>
        <zip>196247</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Saint Petersburg</city>
        <zip>197022</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Saint-Petersburg</city>
        <zip>194044</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Saint-Petersburg</city>
        <zip>197341</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Saratov</city>
        <zip>410012</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Saratov</city>
        <zip>410028</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>St-Petersburg</city>
        <zip>191119</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>St. Petersburg</city>
        <zip>198013</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Tyumen</city>
        <zip>625026</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Volgograd</city>
        <zip>400001</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Volgograd</city>
        <zip>400008</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Voronezh</city>
        <zip>394065</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Yaroslavl</city>
        <zip>150000</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Yaroslavl</city>
        <zip>150030</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Yaroslavl</city>
        <zip>150062</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Bratislava</city>
        <state>Slovak Republic</state>
        <zip>812 72</zip>
        <country>Slovakia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Bratislava</city>
        <state>Slovak Republic</state>
        <zip>826 06</zip>
        <country>Slovakia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Komarno</city>
        <state>Slovak Republic</state>
        <zip>94575</zip>
        <country>Slovakia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Kosice</city>
        <state>Slovak Republic</state>
        <zip>040 01</zip>
        <country>Slovakia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Kosice</city>
        <state>Slovak republic</state>
        <zip>04166</zip>
        <country>Slovakia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Levice</city>
        <state>Slovak Republic</state>
        <zip>93401</zip>
        <country>Slovakia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Nitra</city>
        <state>Slovak Republic</state>
        <zip>949 01</zip>
        <country>Slovakia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Povazska Bystrica</city>
        <state>Slovak republic</state>
        <zip>01701</zip>
        <country>Slovakia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Presov</city>
        <state>Slovak republic</state>
        <zip>08101</zip>
        <country>Slovakia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Stropkov</city>
        <state>Slovak republic</state>
        <zip>09101</zip>
        <country>Slovakia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Zilina</city>
        <state>Slovak Republic</state>
        <zip>010 01</zip>
        <country>Slovakia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Zilina</city>
        <state>Slovak Republic</state>
        <zip>08001</zip>
        <country>Slovakia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Bardejov</city>
        <zip>085 01</zip>
        <country>Slovakia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Bratislava</city>
        <zip>81369</zip>
        <country>Slovakia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Kosice</city>
        <zip>040 01</zip>
        <country>Slovakia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Kosice</city>
        <zip>04001</zip>
        <country>Slovakia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Lucenec</city>
        <zip>98439</zip>
        <country>Slovakia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Piestany</city>
        <zip>921 01</zip>
        <country>Slovakia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Presov</city>
        <zip>080 01</zip>
        <country>Slovakia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Trebisov</city>
        <zip>075 01</zip>
        <country>Slovakia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Trencin</city>
        <zip>911 01</zip>
        <country>Slovakia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Zilina</city>
        <zip>012 07</zip>
        <country>Slovakia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Soweto</city>
        <state>Gauteng</state>
        <zip>2013</zip>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Benoni</city>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Boksburg</city>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Centurion</city>
        <zip>4001</zip>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Johannesburg</city>
        <zip>2157</zip>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Western Cape</city>
        <zip>7130</zip>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Worcester</city>
        <zip>6850</zip>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Sanlucar de Barrameda</city>
        <state>Andalucia</state>
        <zip>11540</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Sevilla</city>
        <state>Andalucia</state>
        <zip>41009</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Utrera</city>
        <state>Andalucia</state>
        <zip>41710</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Oviedo</city>
        <state>Asturias</state>
        <zip>33011</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Hospitalet de Llobregat</city>
        <state>Barcelona</state>
        <zip>08907</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Villamartin</city>
        <state>Cadiz</state>
        <zip>11650</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Badalona</city>
        <state>Catalunya</state>
        <zip>08916</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Barcelona</city>
        <state>Catalunya</state>
        <zip>08035</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Barcelona</city>
        <state>Catalunya</state>
        <zip>08036</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Tarragona</city>
        <state>Catalunya</state>
        <zip>43005</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Tortosa</city>
        <state>Cataluña</state>
        <zip>43500</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Alicante</city>
        <state>Comunidad Valenciana</state>
        <zip>03004</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Valencia</city>
        <state>Comunidad Valenciana</state>
        <zip>46014</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Santiago de Compostela</city>
        <state>Galicia</state>
        <zip>15706</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Majadahonda</city>
        <state>Madrid</state>
        <zip>28222</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Valdemoro</city>
        <state>Madrid</state>
        <zip>28342</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Barcelona</city>
        <zip>08041</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Madrid</city>
        <zip>28007</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Madrid</city>
        <zip>28040</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Madrid</city>
        <zip>28041</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Madrid</city>
        <zip>28046</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Madrid</city>
        <zip>28049</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Falun</city>
        <zip>791 82</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Göteborg</city>
        <zip>416 85</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Karlstad</city>
        <zip>681 85</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Linkoping</city>
        <zip>581 85</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Lund</city>
        <zip>SE-222 21</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Malmo</city>
        <zip>SE 211 36</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Malmö</city>
        <zip>205 02</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Malmö</city>
        <zip>214 22</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Mölndal</city>
        <zip>431 80</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Nässjö</city>
        <zip>SE 571 31</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Skelleftea</city>
        <zip>931 86</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Stockholm</city>
        <zip>111 57</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Stockholm</city>
        <zip>112 81</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Stockholm</city>
        <zip>17176</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Stockholm</city>
        <zip>SE-111 35</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Sundsvall</city>
        <zip>851 86</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Sundsvall</city>
        <zip>852 31</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Umeå</city>
        <zip>901 85</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Uppsala</city>
        <zip>SE-751 85</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Västerås</city>
        <zip>s-721 89</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Örebro</city>
        <zip>701 85</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Basel</city>
        <zip>4031</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Bellinzona</city>
        <zip>6500</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Bern</city>
        <zip>3010</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Biel</city>
        <zip>2500</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Bruderholz</city>
        <zip>4101</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Lugano</city>
        <zip>6903</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Olten</city>
        <zip>4600</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Winterthur</city>
        <zip>8401</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Zuerich</city>
        <zip>8091</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Yongkang</city>
        <state>Tainan</state>
        <zip>71004</zip>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Tainan 704</city>
        <state>Taiwan ROC</state>
        <zip>70403</zip>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Kaohsiung</city>
        <zip>807</zip>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Lin-Kou</city>
        <zip>33305</zip>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Niaosong Township</city>
        <zip>83301</zip>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Taichung</city>
        <zip>40447</zip>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Taipei</city>
        <zip>10002</zip>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Taipei</city>
        <zip>104</zip>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Bangkok</city>
        <zip>10330</zip>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Bangkok</city>
        <zip>10400</zip>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Bangkok</city>
        <zip>10700</zip>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Chiang Mai</city>
        <zip>50200</zip>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Ankara</city>
        <zip>06100</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Aydin</city>
        <zip>09100</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Balcova / Izmir</city>
        <zip>35340</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Etlik / Ankara</city>
        <zip>06018</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Fatih / Istanbul</city>
        <zip>34098</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Istanbul</city>
        <zip>34304</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Izmir</city>
        <zip>35040</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Kinikli / Denizli</city>
        <zip>20070</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Kocaeli</city>
        <zip>41380</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Sivas</city>
        <zip>58140</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Leicester</city>
        <state>Leicestershire</state>
        <zip>LE3 9QP</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Dafen</city>
        <state>Llanelli</state>
        <zip>SA14 8QF</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Addlestone</city>
        <state>Surrey</state>
        <zip>KT15 2BH</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Chichester</city>
        <state>West Sussex</state>
        <zip>PO19 6SE</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Worthing</city>
        <state>West Sussex</state>
        <zip>BN11 2DH</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Cardiff</city>
        <zip>CF5 4AD</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Chesterfield</city>
        <zip>S44 5BL</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Colchester</city>
        <zip>CO4 5JL</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>East Yorkshire</city>
        <zip>HU16 5JQ</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Glasgow</city>
        <zip>G51 4TF</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Liverpool</city>
        <zip>L14 3PE</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>London</city>
        <zip>SE1 7EH</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>London</city>
        <zip>SW17 0RE</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Manchester</city>
        <zip>M23 9LT</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Southampton</city>
        <zip>SO16 6YD</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Swindon</city>
        <zip>SN3 6BB</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Caracas</city>
        <state>Distrito Capital</state>
        <zip>1010</zip>
        <country>Venezuela</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Caracas</city>
        <state>Distrito Capital</state>
        <zip>1040</zip>
        <country>Venezuela</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Caracas</city>
        <state>Distrito Capital</state>
        <zip>1060</zip>
        <country>Venezuela</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Valencia</city>
        <state>Edo. Carabobo</state>
        <zip>2001</zip>
        <country>Venezuela</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Barcelona</city>
        <state>Estado Anzoátegui</state>
        <zip>6001</zip>
        <country>Venezuela</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Puerto Ordaz</city>
        <state>Estado Bolívar</state>
        <zip>8050</zip>
        <country>Venezuela</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Caracas</city>
        <state>Estado Miranda</state>
        <zip>1061</zip>
        <country>Venezuela</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Cumana</city>
        <state>Estado Sucre</state>
        <zip>6101</zip>
        <country>Venezuela</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Maracaibo</city>
        <state>Estado Zulia</state>
        <zip>4011</zip>
        <country>Venezuela</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Argentina</country>
    <country>Australia</country>
    <country>Austria</country>
    <country>Belgium</country>
    <country>Brazil</country>
    <country>Canada</country>
    <country>China</country>
    <country>Colombia</country>
    <country>Costa Rica</country>
    <country>Czech Republic</country>
    <country>Denmark</country>
    <country>Dominican Republic</country>
    <country>Estonia</country>
    <country>Finland</country>
    <country>France</country>
    <country>Germany</country>
    <country>Greece</country>
    <country>India</country>
    <country>Ireland</country>
    <country>Italy</country>
    <country>Japan</country>
    <country>Korea, Republic of</country>
    <country>Latvia</country>
    <country>Lithuania</country>
    <country>Mexico</country>
    <country>Netherlands</country>
    <country>Norway</country>
    <country>Peru</country>
    <country>Poland</country>
    <country>Portugal</country>
    <country>Puerto Rico</country>
    <country>Romania</country>
    <country>Russian Federation</country>
    <country>Slovakia</country>
    <country>South Africa</country>
    <country>Spain</country>
    <country>Sweden</country>
    <country>Switzerland</country>
    <country>Taiwan</country>
    <country>Thailand</country>
    <country>Turkey</country>
    <country>United Kingdom</country>
    <country>United States</country>
    <country>Venezuela</country>
  </location_countries>
  <removed_countries>
    <country>Hungary</country>
    <country>Iceland</country>
  </removed_countries>
  <verification_date>October 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 26, 2009</study_first_submitted>
  <study_first_submitted_qc>February 27, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 2, 2009</study_first_posted>
  <results_first_submitted>October 3, 2016</results_first_submitted>
  <results_first_submitted_qc>October 3, 2016</results_first_submitted_qc>
  <results_first_posted type="Estimate">November 25, 2016</results_first_posted>
  <last_update_submitted>October 3, 2016</last_update_submitted>
  <last_update_submitted_qc>October 3, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 25, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Chronic Heart Failure</keyword>
  <keyword>Cardiovascular death</keyword>
  <keyword>CHF hospitalization</keyword>
  <keyword>morbi-mortality trial</keyword>
  <keyword>outcome study</keyword>
  <keyword>endpoint driven</keyword>
  <keyword>plasma renin activity</keyword>
  <keyword>renin angiotensin aldosterone system</keyword>
  <keyword>direct renin inhibitors</keyword>
  <keyword>BNP</keyword>
  <keyword>KCCQ</keyword>
  <keyword>eGFR</keyword>
  <keyword>(NYHA class II to IV) with elevated</keyword>
  <keyword>BNP and reduced LVEF</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Enalapril</mesh_term>
    <mesh_term>Enalaprilat</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <pre_assignment_details>During Active Run-in period, patients received enalapril for step 1 &amp; 2 and then aliskiren on top of the max tolerated dose of enalapril for step 3. Patients who completed the run in were randomized in a 1:1:1 ratio to one of the 3 treatment arms (aliskiren/enalapril combination therapy, aliskiren monotherapy, or enalapril monotherapy).</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Combination Aliskiren / Enalapril</title>
          <description>Aliskiren / Enalapril combination therapy-150 mg/10 mg titrated to 300 mg/ 10 mg film-coated tablets and administered orally.</description>
        </group>
        <group group_id="P2">
          <title>Aliskiren</title>
          <description>Aliskiren monotherapy - 150 mg titrated to 300 mg film-coated tablets and administered orally.</description>
        </group>
        <group group_id="P3">
          <title>Enalapril</title>
          <description>Enalapril monotherapy -10 mg film-coated tablet and administered orally.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="2354"/>
                <participants group_id="P2" count="2356"/>
                <participants group_id="P3" count="2354"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>Full Analysis Set (FAS)</title>
              <participants_list>
                <participants group_id="P1" count="2340"/>
                <participants group_id="P2" count="2340"/>
                <participants group_id="P3" count="2336"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>Safety Set</title>
              <participants_list>
                <participants group_id="P1" count="2347"/>
                <participants group_id="P2" count="2348"/>
                <participants group_id="P3" count="2345"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1567"/>
                <participants group_id="P2" count="1524"/>
                <participants group_id="P3" count="1539"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="787"/>
                <participants group_id="P2" count="832"/>
                <participants group_id="P3" count="815"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Death</title>
              <participants_list>
                <participants group_id="P1" count="713"/>
                <participants group_id="P2" count="768"/>
                <participants group_id="P3" count="753"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="11"/>
                <participants group_id="P2" count="6"/>
                <participants group_id="P3" count="11"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>H.A. Request</title>
              <participants_list>
                <participants group_id="P1" count="26"/>
                <participants group_id="P2" count="23"/>
                <participants group_id="P3" count="19"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>IRB request</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="2"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Vital Status known (alive) at study end</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="3"/>
                <participants group_id="P3" count="3"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Vital Status unknown at study end</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="1"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Vital Status at study end N/A</title>
              <participants_list>
                <participants group_id="P1" count="8"/>
                <participants group_id="P2" count="10"/>
                <participants group_id="P3" count="10"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Patient's request</title>
              <participants_list>
                <participants group_id="P1" count="21"/>
                <participants group_id="P2" count="17"/>
                <participants group_id="P3" count="11"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Missing study completion information</title>
              <participants_list>
                <participants group_id="P1" count="5"/>
                <participants group_id="P2" count="4"/>
                <participants group_id="P3" count="6"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>Full Analysis Set (FAS) - included all randomized patients but excluded 48 patients (22 mis-randomized but took no double blind and 26 patients due to GCP violations)</population>
      <group_list>
        <group group_id="B1">
          <title>Combination Aliskiren / Enalapril</title>
          <description>Aliskiren / Enalapril combination therapy-150 mg/10 mg titrated to 300 mg/ 10 mg film-coated tablets and administered orally.</description>
        </group>
        <group group_id="B2">
          <title>Aliskiren</title>
          <description>Aliskiren monotherapy - 150 mg titrated to 300 mg film-coated tablets and administered orally.</description>
        </group>
        <group group_id="B3">
          <title>Enalapril</title>
          <description>Enalapril monotherapy -10 mg film-coated tablet and administered orally.</description>
        </group>
        <group group_id="B4">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="2340"/>
            <count group_id="B2" value="2340"/>
            <count group_id="B3" value="2336"/>
            <count group_id="B4" value="7016"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="63.2" spread="11.65"/>
                    <measurement group_id="B2" value="63.3" spread="12.06"/>
                    <measurement group_id="B3" value="63.3" spread="11.71"/>
                    <measurement group_id="B4" value="63.2" spread="11.81"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="494"/>
                    <measurement group_id="B2" value="532"/>
                    <measurement group_id="B3" value="499"/>
                    <measurement group_id="B4" value="1525"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1846"/>
                    <measurement group_id="B2" value="1808"/>
                    <measurement group_id="B3" value="1837"/>
                    <measurement group_id="B4" value="5491"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Number of Participants That Had First Occurrence of the Composite Endpoint, Which is Defined as Either Cardiovascular (CV) Death or Heart Failure (HF) Hospitalization</title>
        <description>Number of participants that had first occurrence of the composite endpoint, which is defined as either CV death or HF hospitalization due to HF.</description>
        <time_frame>up to End of Study (78 months)</time_frame>
        <population>Full Analysis Set (FAS) - All randomized patients with exception of mis-randomized patients that took no study drug and patients from the sites with major GCP violations.</population>
        <group_list>
          <group group_id="O1">
            <title>Combination Aliskiren / Enalapril</title>
            <description>Aliskiren / Enalapril combination therapy-150 mg/10 mg titrated to 300 mg/ 10 mg film-coated tablets and administered orally.</description>
          </group>
          <group group_id="O2">
            <title>Aliskiren</title>
            <description>Aliskiren monotherapy - 150 mg titrated to 300 mg film-coated tablets and administered orally.</description>
          </group>
          <group group_id="O3">
            <title>Enalapril</title>
            <description>Enalapril monotherapy -10 mg film-coated tablet and administered orally.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants That Had First Occurrence of the Composite Endpoint, Which is Defined as Either Cardiovascular (CV) Death or Heart Failure (HF) Hospitalization</title>
          <description>Number of participants that had first occurrence of the composite endpoint, which is defined as either CV death or HF hospitalization due to HF.</description>
          <population>Full Analysis Set (FAS) - All randomized patients with exception of mis-randomized patients that took no study drug and patients from the sites with major GCP violations.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="2340"/>
                <count group_id="O2" value="2340"/>
                <count group_id="O3" value="2336"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Primary Composite</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="770"/>
                    <measurement group_id="O2" value="791"/>
                    <measurement group_id="O3" value="808"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CV death</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="512"/>
                    <measurement group_id="O2" value="562"/>
                    <measurement group_id="O3" value="547"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1st HF Hospitalization</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="430"/>
                    <measurement group_id="O2" value="442"/>
                    <measurement group_id="O3" value="452"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>(superiority)</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.1724</p_value>
            <method>Regression, Cox</method>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>0.93</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.85</ci_lower_limit>
            <ci_upper_limit>1.03</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>(superiority) Non-Diabetic patients</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.4579</p_value>
            <method>Regression, Cox</method>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>0.96</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.85</ci_lower_limit>
            <ci_upper_limit>1.07</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Pre-specified Non-inferiority margin 1.104 is used.</non_inferiority_desc>
            <p_value>0.0368</p_value>
            <method>Regression, Cox</method>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>0.99</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.90</ci_lower_limit>
            <ci_upper_limit>1.10</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>(superiority)</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.9118</p_value>
            <method>Regression, Cox</method>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>0.99</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.90</ci_lower_limit>
            <ci_upper_limit>1.10</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change From Baseline to Month 12 for the Kansas City Cardiomyopathy Questionnaire (KCCQ) Clinical Summary Score</title>
        <description>Change from baseline to Month 12 for the Kansas City Cardiomyopathy Questionnaire (KCCQ) clinical summary score. KCCQ is a 23-item, self-administered instrument that quantifies physical function, symptoms (frequency, severity and recent change), social function, self-efficacy and knowledge, and quality of life. KCCQ clinical summary score is a composite assessment of physical limitations and total symptom scores. Scores are transformed to a range of 0-100, in which higher scores reflect better health status.</description>
        <time_frame>Baseline, Month 12</time_frame>
        <population>Full Analysis Set (FAS) - All randomized patients with exception of mis-randomized patients that took no study drug and patients from the sites with major GCP violations.</population>
        <group_list>
          <group group_id="O1">
            <title>Combination Aliskiren / Enalapril</title>
            <description>Aliskiren / Enalapril combination therapy-150 mg/10 mg titrated to 300 mg/ 10 mg film-coated tablets and administered orally.</description>
          </group>
          <group group_id="O2">
            <title>Aliskiren</title>
            <description>Aliskiren monotherapy - 150 mg titrated to 300 mg film-coated tablets and administered orally.</description>
          </group>
          <group group_id="O3">
            <title>Enalapril</title>
            <description>Enalapril monotherapy -10 mg film-coated tablet and administered orally.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline to Month 12 for the Kansas City Cardiomyopathy Questionnaire (KCCQ) Clinical Summary Score</title>
          <description>Change from baseline to Month 12 for the Kansas City Cardiomyopathy Questionnaire (KCCQ) clinical summary score. KCCQ is a 23-item, self-administered instrument that quantifies physical function, symptoms (frequency, severity and recent change), social function, self-efficacy and knowledge, and quality of life. KCCQ clinical summary score is a composite assessment of physical limitations and total symptom scores. Scores are transformed to a range of 0-100, in which higher scores reflect better health status.</description>
          <population>Full Analysis Set (FAS) - All randomized patients with exception of mis-randomized patients that took no study drug and patients from the sites with major GCP violations.</population>
          <units>KCCQ Score</units>
          <param>Least Squares Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="2340"/>
                <count group_id="O2" value="2340"/>
                <count group_id="O3" value="2336"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-5.04" spread="0.56"/>
                    <measurement group_id="O2" value="-6.03" spread="0.57"/>
                    <measurement group_id="O3" value="-5.01" spread="0.55"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>All Cause Death</title>
        <description>Number of patients - All-cause death. All-cause death is common in Heart Failure HF patients this measures how many patients had this event.</description>
        <time_frame>up to end of study (78 months)</time_frame>
        <population>Full Analysis Set (FAS) - All randomized patients with exception of mis-randomized patients that took no study drug and patients from the sites with major GCP violations</population>
        <group_list>
          <group group_id="O1">
            <title>Combination Aliskiren / Enalapril</title>
            <description>Aliskiren / Enalapril combination therapy-150 mg/10 mg titrated to 300 mg/ 10 mg film-coated tablets and administered orally.</description>
          </group>
          <group group_id="O2">
            <title>Aliskiren</title>
            <description>Aliskiren monotherapy - 150 mg titrated to 300 mg film-coated tablets and administered orally.</description>
          </group>
          <group group_id="O3">
            <title>Enalapril</title>
            <description>Enalapril monotherapy -10 mg film-coated tablet and administered orally.</description>
          </group>
        </group_list>
        <measure>
          <title>All Cause Death</title>
          <description>Number of patients - All-cause death. All-cause death is common in Heart Failure HF patients this measures how many patients had this event.</description>
          <population>Full Analysis Set (FAS) - All randomized patients with exception of mis-randomized patients that took no study drug and patients from the sites with major GCP violations</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="2340"/>
                <count group_id="O2" value="2340"/>
                <count group_id="O3" value="2336"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="595"/>
                    <measurement group_id="O2" value="654"/>
                    <measurement group_id="O3" value="646"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <desc>Safety set (SAF) (double-blind phase) – All patients who received at least one dose of double-blind study drug. Patients were analyzed according to treatment received.
Treatment received was considered identical to the randomized treatment if the patient had received at least one dose of the randomized treatment.</desc>
      <group_list>
        <group group_id="E1">
          <title>Combination of Aliskiren and Enalapril</title>
          <description>Aliskiren/Enalapril combination therapy-150 mg/10 mg titrated to 300 mg/ 10 mg</description>
        </group>
        <group group_id="E2">
          <title>Aliskiren</title>
          <description>Aliskiren monotherapy - 150 mg titrated to 300 mg film-coated tablets and administered orally.</description>
        </group>
        <group group_id="E3">
          <title>Enalapril</title>
          <description>Enalapril monotherapy -10 mg film-coated tablet and administered orally.</description>
        </group>
      </group_list>
      <serious_events>
        <default_vocab>MedDRA</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="1466" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1504" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1501" subjects_at_risk="2345"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>Acquired haemophilia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Anaemia</sub_title>
                <counts group_id="E1" subjects_affected="36" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="28" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="28" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Anaemia vitamin B12 deficiency</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Aplastic anaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Bicytopenia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Bone marrow infiltration</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Coagulopathy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Disseminated intravascular coagulation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Febrile neutropenia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Haemolytic anaemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Haemorrhagic anaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Haemorrhagic diathesis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Hypochromic anaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Hypocoagulable state</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Iron deficiency anaemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Jaundice acholuric</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Leukocytosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Leukopenia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Lymphadenitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Lymphadenopathy mediastinal</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Microcytic anaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Normochromic normocytic anaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Pancytopenia</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Polycythaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Retroperitoneal lymphadenopathy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Splenic embolism</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Splenic infarction</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Splenic vein thrombosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Thrombocytopenia</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="2345"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Acute coronary syndrome</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="18" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="16" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Acute left ventricular failure</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="9" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Acute myocardial infarction</sub_title>
                <counts group_id="E1" subjects_affected="49" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="40" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="46" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Adams-Stokes syndrome</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Angina pectoris</sub_title>
                <counts group_id="E1" subjects_affected="35" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="33" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="37" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Angina unstable</sub_title>
                <counts group_id="E1" subjects_affected="47" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="48" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="41" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Aortic valve disease</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Aortic valve incompetence</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Aortic valve stenosis</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Arrhythmia</sub_title>
                <counts group_id="E1" subjects_affected="13" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="15" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="12" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Arrhythmia supraventricular</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Arteriosclerosis coronary artery</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Atrial fibrillation</sub_title>
                <counts group_id="E1" subjects_affected="89" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="98" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="97" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Atrial flutter</sub_title>
                <counts group_id="E1" subjects_affected="15" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="21" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="11" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Atrial tachycardia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Atrial thrombosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Atrioventricular block</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Atrioventricular block complete</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="8" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="13" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Atrioventricular block first degree</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Atrioventricular block second degree</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="6" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Bifascicular block</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Bradyarrhythmia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Bradycardia</sub_title>
                <counts group_id="E1" subjects_affected="12" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="12" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="9" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Bundle branch block</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Bundle branch block left</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Cardiac aneurysm</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Cardiac arrest</sub_title>
                <counts group_id="E1" subjects_affected="59" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="61" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="59" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Cardiac asthma</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Cardiac discomfort</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Cardiac disorder</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Cardiac failure</sub_title>
                <counts group_id="E1" subjects_affected="480" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="521" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="503" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Cardiac failure acute</sub_title>
                <counts group_id="E1" subjects_affected="54" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="43" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="60" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Cardiac failure chronic</sub_title>
                <counts group_id="E1" subjects_affected="120" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="125" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="122" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Cardiac failure congestive</sub_title>
                <counts group_id="E1" subjects_affected="76" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="85" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="79" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Cardiac flutter</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Cardiac hypertrophy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Cardiac perforation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Cardiac sarcoidosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Cardiac tamponade</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Cardiac valve disease</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Cardiac ventricular thrombosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Cardio-respiratory arrest</sub_title>
                <counts group_id="E1" subjects_affected="24" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="24" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="20" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Cardiogenic shock</sub_title>
                <counts group_id="E1" subjects_affected="31" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="49" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="38" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Cardiomegaly</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Cardiomyopathy</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Cardiopulmonary failure</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Cardiorenal syndrome</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Cardiovascular disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Cardiovascular insufficiency</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Chordae tendinae rupture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Chronotropic incompetence</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Congestive cardiomyopathy</sub_title>
                <counts group_id="E1" subjects_affected="14" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="14" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="19" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Coronary artery disease</sub_title>
                <counts group_id="E1" subjects_affected="28" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="27" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="22" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Coronary artery insufficiency</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Coronary artery occlusion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Coronary artery stenosis</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="8" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Coronary artery thrombosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Extrasystoles</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Heart valve incompetence</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Hypertensive heart disease</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Ischaemic cardiomyopathy</sub_title>
                <counts group_id="E1" subjects_affected="13" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="13" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Left ventricular dysfunction</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="8" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Left ventricular failure</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="6" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Metabolic cardiomyopathy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Mitral valve incompetence</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="17" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="14" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Mitral valve prolapse</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Mitral valve stenosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Myocardial infarction</sub_title>
                <counts group_id="E1" subjects_affected="56" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="50" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="50" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Myocardial ischaemia</sub_title>
                <counts group_id="E1" subjects_affected="19" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="19" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="18" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Nodal rhythm</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Palpitations</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Papillary muscle rupture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Pericardial effusion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Pericarditis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Pulmonary valve incompetence</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Pulseless electrical activity</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Restrictive cardiomyopathy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Rhythm idioventricular</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Right ventricular failure</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Sinoatrial block</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Sinus arrhythmia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Sinus bradycardia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Sinus node dysfunction</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Supraventricular extrasystoles</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Supraventricular tachyarrhythmia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Supraventricular tachycardia</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Systolic dysfunction</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Tachyarrhythmia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Tachycardia</sub_title>
                <counts group_id="E1" subjects_affected="9" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Tachycardia paroxysmal</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Tricuspid valve disease</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Tricuspid valve incompetence</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Ventricular arrhythmia</sub_title>
                <counts group_id="E1" subjects_affected="14" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="8" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="14" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Ventricular dysfunction</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Ventricular dyssynchrony</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Ventricular extrasystoles</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="9" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Ventricular failure</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Ventricular fibrillation</sub_title>
                <counts group_id="E1" subjects_affected="32" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="30" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="34" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Ventricular flutter</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Ventricular tachyarrhythmia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Ventricular tachycardia</sub_title>
                <counts group_id="E1" subjects_affected="78" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="67" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="63" subjects_at_risk="2345"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Congenital, familial and genetic disorders</title>
            <event_list>
              <event>
                <sub_title>Atrial septal defect</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Dermoid cyst</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Hydrocele</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="2345"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Ear and labyrinth disorders</title>
            <event_list>
              <event>
                <sub_title>Deafness neurosensory</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Deafness unilateral</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Haematotympanum</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Meniere's disease</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Sudden hearing loss</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Tympanic membrane perforation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Vertigo</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Vertigo positional</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Endocrine disorders</title>
            <event_list>
              <event>
                <sub_title>Goitre</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Hyperthyroidism</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Hypothyroidism</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Thyrotoxic crisis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Toxic nodular goitre</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Eye disorders</title>
            <event_list>
              <event>
                <sub_title>Amaurosis fugax</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Amblyopia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Cataract</sub_title>
                <counts group_id="E1" subjects_affected="13" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="8" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="6" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Conjunctival haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Diabetic retinopathy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Glaucoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Macular hole</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Ocular fistula</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Ocular retrobulbar haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Ophthalmic vein thrombosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Retinal artery embolism</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Retinal artery occlusion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Retinal degeneration</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Retinal detachment</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Retinal haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Retinal vein occlusion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Retinopathy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Visual acuity reduced</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Vitreous haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Abdominal adhesions</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Abdominal discomfort</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Abdominal distension</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Abdominal hernia</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Abdominal pain</sub_title>
                <counts group_id="E1" subjects_affected="14" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="10" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="11" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Abdominal pain lower</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Abdominal pain upper</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Abdominal strangulated hernia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Abdominal wall haematoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Acid peptic disease</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Acute abdomen</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Alcoholic pancreatitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Anal fissure</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Anal fistula</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Anal prolapse</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Ascites</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="6" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Autoimmune pancreatitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Chronic gastritis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Colitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Colitis ischaemic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Colitis ulcerative</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Constipation</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Crohn's disease</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Dental caries</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Diabetic gastroparesis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Diarrhoea</sub_title>
                <counts group_id="E1" subjects_affected="18" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="11" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Dieulafoy's vascular malformation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Diverticular perforation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Diverticulum</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Diverticulum intestinal</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Diverticulum intestinal haemorrhagic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Duodenal ulcer</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Duodenal ulcer haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Duodenal ulcer perforation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Duodenitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Dyspepsia</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Dysphagia</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Enteritis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Enterocolitis</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Enterovesical fistula</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Eosinophilic oesophagitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Epigastric discomfort</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Erosive duodenitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Erosive oesophagitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Faecaloma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Femoral hernia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Femoral hernia, obstructive</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Gastric haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Gastric polyps</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Gastric ulcer</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="8" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Gastric ulcer haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Gastric ulcer perforation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Gastritis</sub_title>
                <counts group_id="E1" subjects_affected="10" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Gastritis erosive</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Gastritis haemorrhagic</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Gastroduodenal ulcer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Gastrointestinal angiodysplasia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Gastrointestinal haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="19" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="13" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="11" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Gastrointestinal inflammation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Gastrointestinal ischaemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Gastrointestinal necrosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Gastrointestinal polyp haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Gastrointestinal ulcer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Gastrooesophageal reflux disease</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Gingival bleeding</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Haematemesis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Haematochezia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Haemorrhagic erosive gastritis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Haemorrhoidal haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Haemorrhoids</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Hiatus hernia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Ileus</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Ileus paralytic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Incarcerated inguinal hernia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Incarcerated umbilical hernia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Inguinal hernia</sub_title>
                <counts group_id="E1" subjects_affected="23" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="21" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="14" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Intestinal fistula</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Intestinal haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Intestinal infarction</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Intestinal ischaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Intestinal obstruction</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Intestinal perforation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Intestinal polyp</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Intestinal strangulation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Irritable bowel syndrome</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Large intestinal stenosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Large intestine perforation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Large intestine polyp</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Lower gastrointestinal haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Mallory-Weiss syndrome</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Melaena</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Mesenteric artery embolism</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Mesenteric artery thrombosis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Mesenteritis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Mouth haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Nausea</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Obstruction gastric</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Oedematous pancreatitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Oesophageal haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Oesophageal ulcer</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Oesophageal ulcer haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Oesophagitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Oesophagitis haemorrhagic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Pancreatic cyst</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Pancreatitis</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Pancreatitis acute</sub_title>
                <counts group_id="E1" subjects_affected="9" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Pancreatitis chronic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Pancreatitis necrotising</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Peptic ulcer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Peptic ulcer haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Peptic ulcer perforation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Pharyngo-oesophageal diverticulum</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Portal hypertensive gastropathy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Proctalgia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Proctitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Rectal haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Rectal polyp</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Rectal prolapse</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Small intestinal obstruction</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Stress ulcer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Subileus</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Thrombosis mesenteric vessel</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Tongue oedema</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Tooth disorder</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Umbilical hernia</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Upper gastrointestinal haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="12" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="7" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Visceral congestion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Volvulus</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Volvulus of small bowel</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Vomiting</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="2345"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Abasia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Accidental death</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Asthenia</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Brain death</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Cardiac complication associated with device</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Cardiac death</sub_title>
                <counts group_id="E1" subjects_affected="51" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="68" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="87" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Chest discomfort</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Chest pain</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Death</sub_title>
                <counts group_id="E1" subjects_affected="75" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="84" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="82" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Device battery issue</sub_title>
                <counts group_id="E1" subjects_affected="13" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="9" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="14" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Device breakage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Device defective</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Device dislocation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Device electrical impedance issue</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Device end of service</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Device failure</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Device inappropriate shock delivery</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Device issue</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Device lead damage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Device lead issue</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Device malfunction</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="10" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="9" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Device signal detection issue</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Device stimulation issue</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Disease progression</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Drug withdrawal syndrome</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Exercise tolerance decreased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Fatigue</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Feeling abnormal</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Gait disturbance</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>General physical health deterioration</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="7" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Generalised oedema</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Hernia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Hypothermia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Ill-defined disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Impaired healing</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Implant site erosion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Implant site haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Implant site necrosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Implant site pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Implant site ulcer</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Incarcerated hernia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Inflammation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Influenza like illness</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Injury associated with device</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Lead dislodgement</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Localised oedema</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Malaise</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Medical device complication</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Medical device site thrombosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Metaplasia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Multi-organ failure</sub_title>
                <counts group_id="E1" subjects_affected="21" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="15" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="12" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Necrosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Non-cardiac chest pain</sub_title>
                <counts group_id="E1" subjects_affected="13" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="15" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="22" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Oedema</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Oedema peripheral</sub_title>
                <counts group_id="E1" subjects_affected="9" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Organ failure</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Peripheral swelling</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Pyrexia</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="8" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="7" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Stent-graft endoleak</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Sudden cardiac death</sub_title>
                <counts group_id="E1" subjects_affected="38" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="39" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="50" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Sudden death</sub_title>
                <counts group_id="E1" subjects_affected="98" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="89" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="86" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Thrombosis in device</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Ulcer</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Ulcer haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Undersensing</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Vascular stent restenosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Vascular stent stenosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Vascular stent thrombosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2345"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Hepatobiliary disorders</title>
            <event_list>
              <event>
                <sub_title>Acute hepatic failure</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Bile duct obstruction</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Bile duct stenosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Bile duct stone</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Biliary cirrhosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Biliary colic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Biliary dilatation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Cholangitis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Cholangitis acute</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Cholecystitis</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="8" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Cholecystitis acute</sub_title>
                <counts group_id="E1" subjects_affected="9" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="9" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="9" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Cholecystitis chronic</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Cholelithiasis</sub_title>
                <counts group_id="E1" subjects_affected="18" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="15" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="13" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Cholestasis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Chronic hepatitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Cirrhosis alcoholic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Drug-induced liver injury</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Hepatic cirrhosis</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="6" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Hepatic congestion</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Hepatic failure</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Hepatic function abnormal</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Hepatic steatosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Hepatitis</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Hepatitis acute</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Hepatitis alcoholic</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Hepatocellular injury</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Hepatomegaly</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Hepatorenal failure</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Hepatorenal syndrome</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Hepatotoxicity</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Hyperbilirubinaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Ischaemic hepatitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Jaundice</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Jaundice cholestatic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Jaundice hepatocellular</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Liver disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Liver injury</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Non-alcoholic steatohepatitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Portal hypertension</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Immune system disorders</title>
            <event_list>
              <event>
                <sub_title>Allergy to venom</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Anaphylactic reaction</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Anaphylactic shock</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Drug hypersensitivity</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Heart transplant rejection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Transplant rejection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Abdominal abscess</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Abdominal infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Abdominal sepsis</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Abscess intestinal</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Abscess jaw</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Abscess limb</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Abscess oral</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Acinetobacter infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Anal abscess</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Appendiceal abscess</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Appendicitis</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Appendicitis perforated</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Arthritis bacterial</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Arthritis infective</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Atypical pneumonia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Bacteraemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Bacterial diarrhoea</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Bacterial infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Bacterial sepsis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Biliary sepsis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Bone abscess</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Bone tuberculosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Brain abscess</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Bronchitis</sub_title>
                <counts group_id="E1" subjects_affected="22" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="16" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="11" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Bronchitis bacterial</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Bronchitis viral</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Burn infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Bursitis infective</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Campylobacter gastroenteritis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Cardiac valve abscess</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Cellulitis</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="9" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="13" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Cholecystitis infective</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Chronic sinusitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Clostridial infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Clostridium difficile colitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Clostridium difficile infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Corynebacterium infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Cystitis</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Cytomegalovirus infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Dengue fever</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Device related infection</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Device related sepsis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Diabetic foot infection</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Diarrhoea infectious</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Diverticulitis</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Dysentery</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Empyema</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Encephalitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Endocarditis</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Endocarditis bacterial</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Endocarditis staphylococcal</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Enteritis infectious</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Enterococcal sepsis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Epididymitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Erysipelas</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="10" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Escherichia infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Escherichia urinary tract infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Febrile infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Fungal oesophagitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Gangrene</sub_title>
                <counts group_id="E1" subjects_affected="10" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Gastric ulcer helicobacter</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Gastroenteritis</sub_title>
                <counts group_id="E1" subjects_affected="13" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="10" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="16" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Gastroenteritis clostridial</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Gastroenteritis norovirus</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Gastroenteritis viral</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Gastrointestinal infection</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Genitourinary tract infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Groin abscess</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>H1N1 influenza</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Haematoma infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Haemophilus sepsis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Helicobacter infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Hepatic infection bacterial</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Hepatitis B</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Hepatitis viral</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Herpes zoster</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Herpes zoster cutaneous disseminated</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Human ehrlichiosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Implant site infection</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Incision site abscess</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Incision site infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Infected cyst</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Infected seroma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Infected skin ulcer</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Infection</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Infectious colitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Infectious pleural effusion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Infective exacerbation of chronic obstructive airways disease</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Influenza</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Intervertebral discitis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Intestinal sepsis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Klebsiella sepsis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Laryngitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Liver abscess</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Localised infection</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Lower respiratory tract infection</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="9" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Lung abscess</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Lung infection</sub_title>
                <counts group_id="E1" subjects_affected="10" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="13" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Lyme disease</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Mucormycosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Mycobacterial infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Myiasis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Nasopharyngitis</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Necrotising fasciitis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Ophthalmic herpes zoster</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Oral fungal infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Oral infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Orchitis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Oropharyngitis fungal</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Osteomyelitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Otitis media acute</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Otitis media chronic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Parametritis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Paronychia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Periodontitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Peritonitis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="6" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Peritonitis bacterial</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Pneumococcal sepsis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Pneumocystis jirovecii infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Pneumonia</sub_title>
                <counts group_id="E1" subjects_affected="136" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="145" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="122" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Pneumonia bacterial</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Pneumonia escherichia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Pneumonia haemophilus</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Pneumonia influenzal</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Pneumonia mycoplasmal</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Pneumonia pneumococcal</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Pneumonia pseudomonal</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Pneumonia staphylococcal</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Pneumonia viral</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Post procedural infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Post procedural sepsis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Postoperative wound infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Prostatic abscess</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Pseudomembranous colitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Pseudomonal sepsis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Pseudomonas infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Psoas abscess</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Pulmonary sepsis</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Pulmonary tuberculosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Pyelonephritis</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Pyelonephritis acute</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Pyelonephritis chronic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Rectal abscess</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Respiratory tract infection</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="15" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="19" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Respiratory tract infection bacterial</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Respiratory tract infection fungal</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Respiratory tract infection viral</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Sepsis</sub_title>
                <counts group_id="E1" subjects_affected="14" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="18" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="12" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Septic necrosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Septic shock</sub_title>
                <counts group_id="E1" subjects_affected="13" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="21" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="13" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Sialoadenitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Sinusitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Skin bacterial infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Skin infection</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Soft tissue infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Spinal cord infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Staphylococcal bacteraemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Staphylococcal infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Staphylococcal sepsis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Streptococcal endocarditis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Streptococcal sepsis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Subcutaneous abscess</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Thrombophlebitis septic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Tooth abscess</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Tooth infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Tracheitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Tracheobronchitis</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Upper respiratory tract infection</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="6" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Upper respiratory tract infection bacterial</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Urethritis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Urinary tract infection</sub_title>
                <counts group_id="E1" subjects_affected="22" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="21" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="19" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Urinary tract infection bacterial</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Urinary tract infection pseudomonal</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Urosepsis</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Viral infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Viral pericarditis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Viral upper respiratory tract infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Viral vasculitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Wound infection</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Wound infection bacterial</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Wound infection staphylococcal</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Wound sepsis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Accident</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Accidental exposure to product</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Accidental overdose</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Acetabulum fracture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Alcohol poisoning</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Anastomotic complication</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Anastomotic ulcer</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Ankle fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Avulsion fracture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Bone contusion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Brain contusion</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Burns third degree</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Carbon monoxide poisoning</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Cardiac function disturbance postoperative</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Cardiac procedure complication</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Carotid artery restenosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Cervical vertebral fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Chest injury</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Clavicle fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Closed globe injury</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Comminuted fracture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Complications of transplanted heart</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Concussion</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Contusion</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Coronary artery reocclusion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Coronary artery restenosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Coronary vascular graft occlusion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Craniocerebral injury</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Excoriation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Extradural haematoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Facial bones fracture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Fall</sub_title>
                <counts group_id="E1" subjects_affected="9" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="8" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="11" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Femoral neck fracture</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Femur fracture</sub_title>
                <counts group_id="E1" subjects_affected="9" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="10" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="6" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Fibula fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Foot fracture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Forearm fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Foreign body</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Fracture displacement</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Fractured ischium</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Fractured sacrum</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Gastrointestinal stoma complication</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Hand fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Head injury</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Hip fracture</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Humerus fracture</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Incision site haematoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Incisional hernia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Injury</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Intestinal anastomosis complication</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Joint dislocation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Joint injury</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Laceration</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Ligament injury</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Ligament sprain</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Limb injury</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Limb traumatic amputation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Lip injury</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Lower limb fracture</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Lumbar vertebral fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Meniscus injury</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Mouth injury</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Multiple fractures</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Multiple injuries</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Muscle injury</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Muscle rupture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Overdose</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="9" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Patella fracture</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Pelvic fracture</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Periorbital haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Peripheral artery restenosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Periprosthetic fracture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Pneumothorax traumatic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Poisoning</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Post procedural bile leak</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Post procedural complication</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Post procedural haematoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Post procedural haematuria</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Post procedural haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Post-traumatic pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Postoperative hernia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Postoperative ileus</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Postoperative thoracic procedure complication</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Postoperative wound complication</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Procedural complication</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Procedural pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Product name confusion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Pubis fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Pulmonary contusion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Radius fracture</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Respiratory fume inhalation disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Rib fracture</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="8" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Road traffic accident</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Sacroiliac fracture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Scrotal haematoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Shunt stenosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Skin abrasion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Skin injury</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Skull fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Soft tissue injury</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Spinal compression fracture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Spinal cord injury</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Spinal fracture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Subdural haematoma</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Subdural haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Tendon rupture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Thermal burn</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Thoracic vertebral fracture</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Tibia fracture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Tooth fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Toxicity to various agents</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Transplant failure</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Traumatic fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Traumatic haematoma</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Traumatic haemothorax</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Traumatic intracranial haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Traumatic liver injury</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Traumatic shock</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Ulna fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Underdose</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Upper limb fracture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Urethral stricture traumatic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Vascular bypass dysfunction</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Vascular graft occlusion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Vascular pseudoaneurysm</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Vasoplegia syndrome</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Wound</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Wound haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Investigations</title>
            <event_list>
              <event>
                <sub_title>Anticoagulation drug level below therapeutic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Anticoagulation drug level increased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Blood alkaline phosphatase increased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Blood creatine phosphokinase increased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Blood creatinine increased</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Blood ethanol increased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Blood glucose increased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Blood magnesium decreased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Blood potassium decreased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Blood potassium increased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Blood urine</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Blood urine present</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Brain natriuretic peptide increased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>C-reactive protein increased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Cardiac murmur</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Cardiac output decreased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Cardioactive drug level increased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Chest X-ray abnormal</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Coagulation test abnormal</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Coagulation time prolonged</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Ejection fraction abnormal</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Ejection fraction decreased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Electrocardiogram QRS complex prolonged</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Enterobacter test positive</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Gamma-glutamyltransferase increased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Heart rate decreased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Heart rate irregular</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Hepatic enzyme increased</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>International normalised ratio abnormal</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>International normalised ratio increased</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="6" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Lipase increased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Oxygen saturation decreased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Prostatic specific antigen increased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Transaminases increased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Urine output decreased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Viral load increased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Weight decreased</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Weight increased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>White blood cell count increased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>Acidosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Cachexia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Carbohydrate intolerance</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Decreased appetite</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Dehydration</sub_title>
                <counts group_id="E1" subjects_affected="27" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="21" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="14" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Diabetes mellitus</sub_title>
                <counts group_id="E1" subjects_affected="15" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="16" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="10" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Diabetes mellitus inadequate control</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Diabetic ketoacidosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Electrolyte imbalance</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Fluid overload</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Fluid retention</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Glucose tolerance impaired</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Gout</sub_title>
                <counts group_id="E1" subjects_affected="11" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="11" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Hypercalcaemia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Hyperglycaemia</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Hyperkalaemia</sub_title>
                <counts group_id="E1" subjects_affected="21" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="13" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="20" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Hyperosmolar hyperglycaemic state</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Hyperosmolar state</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Hypertriglyceridaemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Hyperuricaemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Hypervolaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Hypoalbuminaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Hypocalcaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Hypoglycaemia</sub_title>
                <counts group_id="E1" subjects_affected="10" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Hypokalaemia</sub_title>
                <counts group_id="E1" subjects_affected="10" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="12" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="10" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Hypomagnesaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Hyponatraemia</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="10" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Hypophagia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Hypoproteinaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Hypovolaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Insulin resistance</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Iron deficiency</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Ketoacidosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Malnutrition</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Marasmus</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Metabolic acidosis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Metabolic disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Mineral deficiency</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Obesity</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Polydipsia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Type 1 diabetes mellitus</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Type 2 diabetes mellitus</sub_title>
                <counts group_id="E1" subjects_affected="12" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="10" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="8" subjects_at_risk="2345"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Arthralgia</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Arthritis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Back pain</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Bursitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Cervical spinal stenosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Chondropathy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Compartment syndrome</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Connective tissue inflammation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Costochondritis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Diabetic amyotrophy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Fistula</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Flank pain</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Foot deformity</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Fracture malunion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Gouty arthritis</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Haemarthrosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Intervertebral disc degeneration</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Intervertebral disc protrusion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Joint effusion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Joint instability</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Lumbar spinal stenosis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Muscle atrophy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Muscle haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Muscular weakness</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Musculoskeletal chest pain</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Musculoskeletal pain</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Musculoskeletal stiffness</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Myalgia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Myopathy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Myopathy toxic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Myositis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Neck pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Osteitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Osteoarthritis</sub_title>
                <counts group_id="E1" subjects_affected="9" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="12" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="10" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Osteochondritis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Osteochondrosis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Osteonecrosis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Osteonecrosis of jaw</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Osteoporosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Osteoporotic fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Pain in extremity</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="6" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Pathological fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Polyarthritis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Rhabdomyolysis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Rheumatic disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Rheumatoid arthritis</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Rotator cuff syndrome</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Scleroderma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Spinal column stenosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Spinal deformity</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Spinal osteoarthritis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Spinal pain</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Synovial cyst</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Neoplasms benign, malignant and unspecified (incl cysts and polyps)</title>
            <event_list>
              <event>
                <sub_title>Acute myeloid leukaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Adenocarcinoma gastric</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Adenocarcinoma of appendix</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Adenocarcinoma of colon</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="8" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Adrenal adenoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Basal cell carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Benign ear neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Benign lung neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Benign neoplasm of bladder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Benign neoplasm of skin</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Benign neoplasm of spinal cord</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Benign neoplasm of thyroid gland</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Benign pancreatic neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Benign renal neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Benign salivary gland neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Bile duct adenocarcinoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Bile duct cancer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Bladder cancer</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="6" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Bladder cancer recurrent</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Bladder neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Bladder papilloma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Bladder transitional cell carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Bone cancer</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Brain neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Brain neoplasm malignant</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Breast cancer</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Breast cancer female</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Bronchial carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="7" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Carcinoma in situ of penis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Carcinoma in situ of skin</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Cardiac valve fibroelastoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Cerebellar tumour</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Cholangiocarcinoma</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Chronic lymphocytic leukaemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Colon adenoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Colon cancer</sub_title>
                <counts group_id="E1" subjects_affected="10" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="7" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Colon cancer metastatic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Colon cancer recurrent</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Colorectal adenocarcinoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Colorectal cancer</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Extranodal marginal zone B-cell lymphoma (MALT type)</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Gallbladder cancer</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Gastric adenoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Gastric cancer</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Gastrointestinal cancer metastatic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Gastrointestinal carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Glioblastoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Glioma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Haemangioma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Hepatic cancer</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Hepatic cancer metastatic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Hepatic neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Hepatobiliary cancer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Hepatocellular carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Hodgkin's disease</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Hypopharyngeal cancer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Infected neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Intestinal adenocarcinoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Invasive ductal breast carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Keratoacanthoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Large intestine benign neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Laryngeal cancer</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Laryngeal squamous cell carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Lentigo maligna</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Lip and/or oral cavity cancer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Lip neoplasm malignant stage unspecified</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Lipoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Lung adenocarcinoma</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Lung adenocarcinoma metastatic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Lung cancer metastatic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Lung carcinoma cell type unspecified stage IV</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Lung neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Lung neoplasm malignant</sub_title>
                <counts group_id="E1" subjects_affected="9" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="9" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="12" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Lymphoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Malignant melanoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Malignant neoplasm of auricular cartilage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Malignant neoplasm of renal pelvis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Malignant palate neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Malignant pleural effusion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Mediastinum neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Meningioma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Meningioma benign</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Metastases to bone</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Metastases to bone marrow</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Metastases to central nervous system</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Metastases to liver</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Metastases to lung</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Metastases to lymph nodes</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Metastases to peritoneum</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Metastases to pleura</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Metastases to spine</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Metastatic malignant melanoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Metastatic pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Metastatic squamous cell carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Myelodysplastic syndrome</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Myeloproliferative disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Nasopharyngeal cancer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Neoplasm malignant</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Neuroendocrine carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Non-Hodgkin's lymphoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Non-small cell lung cancer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Non-small cell lung cancer stage IV</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Oesophageal carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Ovarian cancer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Pancreatic carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Pancreatic carcinoma metastatic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Pancreatic carcinoma stage IV</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Papillary thyroid cancer</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Penile cancer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Pineal parenchymal neoplasm malignant</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Plasma cell myeloma</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Pleural mesothelioma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Prostate cancer</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="19" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Prostate cancer metastatic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Prostatic adenoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Rectal adenocarcinoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Rectal cancer</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Rectosigmoid cancer</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Renal cancer</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Renal cancer metastatic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Renal cell carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Renal neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Salivary gland adenoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Sinus cancer metastatic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Skin cancer</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Small cell lung cancer recurrent</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Squamous cell carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Squamous cell carcinoma of lung</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Squamous cell carcinoma of skin</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Thyroid cancer</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Thyroid neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Tongue neoplasm malignant stage unspecified</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Transitional cell carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Tumour flare</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Tumour haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Tumour pain</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Uterine cancer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Uterine leiomyoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Ageusia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Altered state of consciousness</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Amyotrophic lateral sclerosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Aphasia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Atonic seizures</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Balance disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Basilar artery stenosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Brain hypoxia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Brain injury</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Brain oedema</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Brain stem infarction</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Brain stem syndrome</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Carotid arteriosclerosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Carotid artery disease</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Carotid artery stenosis</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Carpal tunnel syndrome</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Cerebellar ataxia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Cerebellar haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Cerebellar infarction</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Cerebral amyloid angiopathy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Cerebral arteriosclerosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Cerebral artery embolism</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Cerebral artery occlusion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Cerebral atrophy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Cerebral haematoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Cerebral haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="9" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="7" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Cerebral infarction</sub_title>
                <counts group_id="E1" subjects_affected="9" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="17" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="17" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Cerebral ischaemia</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Cerebrovascular accident</sub_title>
                <counts group_id="E1" subjects_affected="44" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="51" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="62" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Cerebrovascular disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Cerebrovascular insufficiency</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Cervicogenic headache</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Cognitive disorder</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Coma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Complex partial seizures</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Dementia</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Depressed level of consciousness</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Diabetic coma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Diabetic hyperosmolar coma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Diabetic neuropathy</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Dizziness</sub_title>
                <counts group_id="E1" subjects_affected="11" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="9" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Dizziness postural</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Dysarthria</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Dyslalia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Embolic cerebral infarction</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Embolic stroke</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Encephalomalacia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Encephalopathy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Epilepsy</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Generalised tonic-clonic seizure</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Haemorrhage intracranial</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Haemorrhagic stroke</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Headache</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Hemianopia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Hemianopia homonymous</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Hemiparesis</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Hemiplegia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Hepatic encephalopathy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Hydrocephalus</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Hypoglycaemic coma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Hypoglycaemic seizure</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Hypoxic-ischaemic encephalopathy</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>IIIrd nerve paresis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Intracranial aneurysm</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Intraventricular haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Ischaemic cerebral infarction</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Ischaemic stroke</sub_title>
                <counts group_id="E1" subjects_affected="45" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="45" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="29" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Lacunar infarction</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Leukoencephalopathy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Loss of consciousness</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Mental retardation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Metabolic encephalopathy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Monoparesis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Monoplegia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Motor neurone disease</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Myelopathy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Myoclonus</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Narcolepsy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Nervous system disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Orthostatic intolerance</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Paraesthesia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Paraparesis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Paresis cranial nerve</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Parkinson's disease</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Parkinsonism</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Partial seizures</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Peripheral sensory neuropathy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Postresuscitation encephalopathy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Presyncope</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="9" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Psychomotor hyperactivity</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Radiculopathy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Restless legs syndrome</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Retrograde amnesia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Reversible ischaemic neurological deficit</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Sciatica</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Seizure</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Somnolence</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Spinal claudication</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Spinal epidural haematoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Subarachnoid haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Syncope</sub_title>
                <counts group_id="E1" subjects_affected="48" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="56" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="27" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Tension headache</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Thalamus haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Transient global amnesia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Transient ischaemic attack</sub_title>
                <counts group_id="E1" subjects_affected="23" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="20" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="15" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Tremor</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Trigeminal nerve disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Uraemic encephalopathy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>VIIth nerve paralysis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Vascular dementia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Vascular encephalopathy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Vertebrobasilar insufficiency</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2345"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>Abulia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Acute psychosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Adjustment disorder</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Alcohol abuse</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Alcohol withdrawal syndrome</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Alcoholism</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Anxiety</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Anxiety disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Apathy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Bipolar disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Catatonia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Completed suicide</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Confusional state</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Delirium</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Delusion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Depression</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Disorientation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Fear</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Insomnia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Major depression</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Mental status changes</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Mood disorder due to a general medical condition</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Psychotic disorder</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Restlessness</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Schizophrenia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Somatisation disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Suicidal ideation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Suicide attempt</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Acute kidney injury</sub_title>
                <counts group_id="E1" subjects_affected="52" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="29" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="38" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Acute prerenal failure</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Anuria</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Azotaemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Calculus bladder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Calculus ureteric</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Calculus urethral</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Calculus urinary</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Chronic kidney disease</sub_title>
                <counts group_id="E1" subjects_affected="21" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="10" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="10" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Diabetic nephropathy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Dysuria</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Glomerulonephritis membranous</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Haematuria</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Hydronephrosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Hypertensive nephropathy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Ischaemic nephropathy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Nephritis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Nephrolithiasis</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Nephropathy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Nephrotic syndrome</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Polyuria</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Postrenal failure</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Prerenal failure</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Proteinuria</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Renal cyst</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Renal disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Renal embolism</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Renal failure</sub_title>
                <counts group_id="E1" subjects_affected="33" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="26" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="27" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Renal impairment</sub_title>
                <counts group_id="E1" subjects_affected="34" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="31" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="33" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Renal infarct</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Renal tubular necrosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Ureteric fistula</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Ureteric stenosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Urethral obstruction</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Urethral stenosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Urinary bladder haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Urinary bladder polyp</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Urinary retention</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Urinary tract obstruction</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Urinoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Reproductive system and breast disorders</title>
            <event_list>
              <event>
                <sub_title>Acquired hydrocele</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Benign prostatic hyperplasia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="9" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="7" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Breast hyperplasia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Mammary fistula</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Menorrhagia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Metrorrhagia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Ovarian cyst</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Postmenopausal haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Prostatic obstruction</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Prostatitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Prostatomegaly</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Rectocele</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Scrotal oedema</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Spermatocele</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Uterine polyp</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Acute pulmonary oedema</sub_title>
                <counts group_id="E1" subjects_affected="20" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="20" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="17" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Acute respiratory distress syndrome</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Acute respiratory failure</sub_title>
                <counts group_id="E1" subjects_affected="13" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="8" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="14" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Alveolitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Apnoea</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Asphyxia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Asthma</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="8" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Asthmatic crisis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Bronchiectasis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Bronchitis chronic</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="8" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Bronchopleural fistula</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Bronchospasm</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Cheyne-Stokes respiration</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Chronic obstructive pulmonary disease</sub_title>
                <counts group_id="E1" subjects_affected="32" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="32" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="43" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Chronic respiratory failure</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Cough</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Diaphragmatic paralysis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Dyspnoea</sub_title>
                <counts group_id="E1" subjects_affected="54" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="46" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="35" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Dyspnoea at rest</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Dyspnoea exertional</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Dyspnoea paroxysmal nocturnal</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Emphysema</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Epistaxis</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="8" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Haemoptysis</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Haemothorax</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Hiccups</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Hydrothorax</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Hypercapnia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Hyperventilation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Hypoxia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Idiopathic pulmonary fibrosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Interstitial lung disease</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Laryngeal oedema</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Lung disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Lung infiltration</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Mediastinal mass</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Nasal septum deviation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Organising pneumonia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Oropharyngeal pain</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Orthopnoea</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Pharyngeal oedema</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Pleural effusion</sub_title>
                <counts group_id="E1" subjects_affected="10" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="11" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="12" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Pleurisy</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Pleurocutaneous fistula</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Pneumomediastinum</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Pneumonia aspiration</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Pneumonitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Pneumothorax</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Pneumothorax spontaneous</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Productive cough</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Pulmonary alveolar haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Pulmonary arterial hypertension</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Pulmonary artery thrombosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Pulmonary congestion</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Pulmonary embolism</sub_title>
                <counts group_id="E1" subjects_affected="17" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="18" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="9" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Pulmonary fibrosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Pulmonary haematoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Pulmonary hypertension</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Pulmonary mass</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Pulmonary oedema</sub_title>
                <counts group_id="E1" subjects_affected="27" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="27" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="14" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Pulmonary venous thrombosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Respiratory arrest</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Respiratory distress</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Respiratory failure</sub_title>
                <counts group_id="E1" subjects_affected="16" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="16" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="26" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Sleep apnoea syndrome</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Snoring</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Suffocation feeling</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Vocal cord leukoplakia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Acquired epidermolysis bullosa</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Actinic keratosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Angioedema</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Decubitus ulcer</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Dermal cyst</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Dermatitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Dermatitis allergic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Dermatitis bullous</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Dermatitis contact</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Diabetic foot</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Diabetic ulcer</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Drug eruption</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Ecchymosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Erythema</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Fungating wound</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Henoch-Schonlein purpura</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Hyperhidrosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Intertrigo</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Lichen sclerosus</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Neuropathic ulcer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Peau d'orange</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Precancerous skin lesion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Pruritus</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Psoriasis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Purpura</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Rash</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Seborrhoeic dermatitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Skin necrosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Skin ulcer</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Skin ulcer haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Toxic skin eruption</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Social circumstances</title>
            <event_list>
              <event>
                <sub_title>Immobile</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Treatment noncompliance</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Surgical and medical procedures</title>
            <event_list>
              <event>
                <sub_title>Heart transplant</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Implantable defibrillator insertion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Accelerated hypertension</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Aneurysm ruptured</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Aortic aneurysm</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="8" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="8" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Aortic aneurysm rupture</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Aortic arteriosclerosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Aortic dilatation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Aortic dissection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Aortic rupture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Aortic stenosis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Aortic thrombosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Arterial insufficiency</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Arterial stenosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Arterial thrombosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Arteriosclerosis</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Arteriovenous fistula</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Arteritis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Bleeding varicose vein</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Circulatory collapse</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Deep vein thrombosis</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Diabetic vascular disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Embolism arterial</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Embolism venous</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Extremity necrosis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Femoral artery embolism</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Femoral artery occlusion</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Haematoma</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Haemodynamic instability</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Hypertension</sub_title>
                <counts group_id="E1" subjects_affected="17" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="13" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="10" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Hypertensive crisis</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Hypertensive emergency</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Hypotension</sub_title>
                <counts group_id="E1" subjects_affected="37" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="49" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="26" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Hypovolaemic shock</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Iliac artery embolism</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Iliac artery occlusion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Intermittent claudication</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Ischaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Ischaemic limb pain</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Orthostatic hypotension</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Peripheral arterial occlusive disease</sub_title>
                <counts group_id="E1" subjects_affected="18" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="13" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="11" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Peripheral artery aneurysm</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Peripheral artery stenosis</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Peripheral artery thrombosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Peripheral embolism</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Peripheral ischaemia</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="8" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Peripheral vascular disorder</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Peripheral venous disease</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Post thrombotic syndrome</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Secondary hypertension</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Shock</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Shock haemorrhagic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Subclavian artery stenosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Thrombophlebitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Thrombophlebitis superficial</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Thrombosis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Varicophlebitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Varicose ulceration</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Varicose vein</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Vascular rupture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Venous haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Venous thrombosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Venous thrombosis limb</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2345"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>3</frequency_threshold>
        <default_vocab>MedDRA</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="1698" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="1605" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="1623" subjects_at_risk="2345"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>Anaemia</sub_title>
                <counts group_id="E1" subjects_affected="124" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="115" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="111" subjects_at_risk="2345"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Angina pectoris</sub_title>
                <counts group_id="E1" subjects_affected="81" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="86" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="71" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Atrial fibrillation</sub_title>
                <counts group_id="E1" subjects_affected="199" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="238" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="184" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Cardiac failure</sub_title>
                <counts group_id="E1" subjects_affected="241" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="254" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="238" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Ventricular tachycardia</sub_title>
                <counts group_id="E1" subjects_affected="55" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="74" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="55" subjects_at_risk="2345"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Constipation</sub_title>
                <counts group_id="E1" subjects_affected="96" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="79" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="82" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Diarrhoea</sub_title>
                <counts group_id="E1" subjects_affected="145" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="117" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="116" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Nausea</sub_title>
                <counts group_id="E1" subjects_affected="68" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="78" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="55" subjects_at_risk="2345"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Fatigue</sub_title>
                <counts group_id="E1" subjects_affected="96" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="107" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="101" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Oedema peripheral</sub_title>
                <counts group_id="E1" subjects_affected="182" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="183" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="176" subjects_at_risk="2345"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Bronchitis</sub_title>
                <counts group_id="E1" subjects_affected="151" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="138" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="147" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Influenza</sub_title>
                <counts group_id="E1" subjects_affected="91" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="62" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="86" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Nasopharyngitis</sub_title>
                <counts group_id="E1" subjects_affected="185" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="187" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="186" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Pneumonia</sub_title>
                <counts group_id="E1" subjects_affected="84" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="95" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="78" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Upper respiratory tract infection</sub_title>
                <counts group_id="E1" subjects_affected="84" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="74" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="79" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Urinary tract infection</sub_title>
                <counts group_id="E1" subjects_affected="92" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="82" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="84" subjects_at_risk="2345"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Investigations</title>
            <event_list>
              <event>
                <sub_title>Blood creatinine increased</sub_title>
                <counts group_id="E1" subjects_affected="97" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="70" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="57" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Glomerular filtration rate decreased</sub_title>
                <counts group_id="E1" subjects_affected="88" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="50" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="79" subjects_at_risk="2345"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>Diabetes mellitus</sub_title>
                <counts group_id="E1" subjects_affected="99" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="96" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="84" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Gout</sub_title>
                <counts group_id="E1" subjects_affected="113" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="88" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="91" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Hyperkalaemia</sub_title>
                <counts group_id="E1" subjects_affected="469" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="283" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="350" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Hyperuricaemia</sub_title>
                <counts group_id="E1" subjects_affected="101" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="108" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="93" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Hypokalaemia</sub_title>
                <counts group_id="E1" subjects_affected="130" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="149" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="116" subjects_at_risk="2345"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Arthralgia</sub_title>
                <counts group_id="E1" subjects_affected="72" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="86" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="71" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Back pain</sub_title>
                <counts group_id="E1" subjects_affected="90" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="82" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="98" subjects_at_risk="2345"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Dizziness</sub_title>
                <counts group_id="E1" subjects_affected="179" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="140" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="144" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Headache</sub_title>
                <counts group_id="E1" subjects_affected="55" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="71" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="67" subjects_at_risk="2345"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>Insomnia</sub_title>
                <counts group_id="E1" subjects_affected="91" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="92" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="98" subjects_at_risk="2345"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Renal impairment</sub_title>
                <counts group_id="E1" subjects_affected="414" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="298" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="328" subjects_at_risk="2345"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Cough</sub_title>
                <counts group_id="E1" subjects_affected="285" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="223" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="286" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Dyspnoea</sub_title>
                <counts group_id="E1" subjects_affected="204" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="216" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="213" subjects_at_risk="2345"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Hypertension</sub_title>
                <counts group_id="E1" subjects_affected="188" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="180" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="137" subjects_at_risk="2345"/>
              </event>
              <event>
                <sub_title>Hypotension</sub_title>
                <counts group_id="E1" subjects_affected="409" subjects_at_risk="2347"/>
                <counts group_id="E2" subjects_affected="308" subjects_at_risk="2348"/>
                <counts group_id="E3" subjects_affected="332" subjects_at_risk="2345"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Study Director</name_or_title>
      <organization>Novartis Pharmaceuticals</organization>
      <phone>862-778-8300</phone>
    </point_of_contact>
  </clinical_results>
</clinical_study>

